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Abstract 
Previous studies found that RdgC protein plays a role in the DNA repair system in 
Escherichia coli. In recBC sbcBC strains, loss of rdgC made growth of the strains 
dependent upon recombination, hence Recombination Dependent Growth. RdgC 
was also found to regulate the activity of RecA, a key protein in recombination, 
both in vivo and in vitro. The function of the protein, however, remains unknown. 
In this study, I purified and crystallised the RdgC protein. The crystal structure of 
the protein was then revealed as a homo-dimer, with a head to head, tail to tail 
organisation, resembling a ring structure. To further investigate how RdgC binds 
DNA and its in vivo functionality, point mutations and chunk deletions were 
designed and constructed; and I examined all the mutant proteins in DNA binding 
shift assays in vitro and in synthetic lethality assays in vivo. A DNA binding model 
was then proposed based on the results of the DNA binding shift assays. The 
mutant studies in vivo reinforce the idea that the DNA binding activity is crucial 
for RdgCs function in Escherichia coli.  
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Chapter 1 
Introduction 
1.1 Overview 
Chromosomal DNA encodes almost all biological traits of a living organism. 
Any changes to it therefore have a potential to interfere with the normal life 
form. Evolution has introduced sophisticated DNA repair systems to limit this 
potential to a minimum, among which is DNA recombinational repair. In 
Escherichia coli, this process is catalysed by RecA, the central protein in 
homologous recombination. The activity of RecA is strictly controlled to avoid 
unnecessary recombination, which is otherwise dangerous. The RdgC protein 
is thought to be a negative regulator of RecA by binding to dsDNA, protecting 
it from being used by an active RecA species. 
In this chapter, DNA damage and repair, RecA mediated DNA recombinational 
repair and its interaction with RdgC are reviewed.  
1.2 DNA damage and repair 
Unlike damaged proteins that can be replaced by using the source codes of 
genes, damaged DNA must be repaired.  
Mismatch repair (MMR) deals with the rare mismatches left after replication. 
In E. coli, the MMR system distinguishes the template strand from the nascent 
strand by methylated adenines, and therefore cuts a segment of the 
unmethylated nascent DNA strand containing the mismatched base. DNA 
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polymerase III and DNA ligase will fill the gap and finish the repair (Kolodner, 
1995). 
Base-excision repair (BER) is active against common DNA lesions (such as the 
products of cytosine and adenine deamination). The repair depends on a variety 
of DNA glycosylases, each of which is generally specific for one type of lesion. 
DNA glycosylases recognise and remove the affected base by cleaving the N-
glycosyl bond, generating an apurinic or apyrimidinic site, commonly referred 
to as an AP site. A segment of DNA including the AP site is then removed by 
AP endonucleases, leaving a gap which will be filled by DNA polymerase I 
and DNA ligase (McCullough et al., 1999). 
Nucleotide-excision repair (NER) generally targets at DNA lesions that cause 
large distortions in the helical structure of DNA. In E. coli, a multisubunit 
enzyme excises a fragment of 12 to 13 nucleotides with the lesion, and the 
resulting gap is filled by DNA polymerase I and DNA ligase (Sancar, 1996). 
Direct repair is special because it does not need a complementary strand to 
provide information. It applies a variety of enzymes that recognise distinctive 
DNA lesions, which commonly arise from typical base modifications. Each of 
these modifications can be reversed by an appropriate class of enzymes. For 
example, pyrimidine dimers resulting from an ultraviolet light-induced reaction 
are usually reversed to two pyrimidines by DNA photolyases in E. coli 
(Murphy et al., 2008). 
The DNA repair mechanisms described above generally work for lesions in 
double-stranded DNA, the undamaged strand providing the correct genetic 
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information to restore the damaged strand to its original state. However, there 
are also situations where the complementary strand is absent or is itself 
damaged, which often arises when a replication fork encounters an unrepaired 
DNA lesion. To overcome it, the DNA repair systems either take a guess over 
the damaged region to fill random codes in (as applied by error-prone 
translesion DNA synthesis, often abbreviated TLS), or repair the damaged 
strand with the genetic information provided by a separate, homologous 
chromosome. The latter is accurate and undoubtedly favoured wherever 
possible. In E. coli, this process is catalysed by RecA, and is also known as 
recombinational DNA repair.  
1.3 RecA mediated recombination 
RecA mediates DNA recombination in prokaryotes as a multi-protein filament 
covering a segment of single-stranded DNA. Filament formation consists of 
two steps: nucleation and extension, with the former generally being rate-
limiting. Nucleation is more rapid on ssDNA and is greatly slowed if SSB 
A B C 
D 
F E 
RecA 
Figure 1-1 RecA mediated homologous recombination. A. ssDNA exposed for RecA binding; B. Filamentation of 
RecA on the exposed ssDNA; C. Re-pairing mediated by the RecA filament; D. Invasion of the branch into duplex 
region; E. Two possible resolutions for the recombination intermediate; F. Two corresponding fates of step E. 
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(Single-Stranded DNA Binding protein) is bound to the ssDNA. Filament 
extension occurs on the 3-proximal end, accompanied with dissociation on the 
opposite end at a slower rate. This filament searches a separate duplex for 
sequence homologous to the covered ssDNA, and then mediates re-pairing so 
that the covered ssDNA anneals with its sequence-complementary strand. The 
resulting DNA branchpoint will be moved by RuvAB or RecG. If the branch is 
driven into a duplex region of the template DNA, it will form a four-way 
junction, also known as Holliday junction (Figure 1-1 D). Resolvases such as 
RuvC may cut the junction, monomerising the recombination intermediate. 
UvsX in bacteriophage T4 (Kodadek et al., 1988; Beernink and Morrical, 
1999), RadA in archaea (Seitz et al., 1998), and Dmc1 (Gupta et al., 2001) and 
Rad51 (Ogawa et al., 1993; Sung, 1994) in eukaryotes are orthologues of RecA 
and act in DNA recombination in a very similar way. Its ubiquitous distribution 
underlines its significance throughout evolution. 
Unlike most other DNA repair pathways that deal with problems on double-
stranded DNA, recombination mediated by RecA focuses on single-stranded 
DNA. It is the substrate at which RecA actsboth for DNA recombination and 
the SOS response. This might raise a potential for initiating recombination 
whenever ssDNA is exposed. However, any exposed ssDNA is immediately 
bound and hence protected by the ssDNA binding protein, SSB. This is almost 
why the RecBCD pathway loads RecA directly to initiate recombination at 
dsDNA ends.  
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1.3.1 The RecBCD pathway 
RecBCD is a DNA helicase and ATP-dependent exonuclease (ExoV) that acts 
on blunt or nearly blunt dsDNA ends (Taylor and Smith, 1985). Free DNA 
duplex ends (DSBs) are caused by a variety of factors. In addition to imperfect 
templates that replication forks act upon, UV light, ionising radiation, oxygen 
radicals, DNA-damaging agents and inappropriate chromosomal DNA 
cleavage may all generate DSBs (Dillingham and Kowalczykowski, 2008).  
The resulting DSBs are not always blunt or nearly blunt and therefore need to 
be trimmed by ssDNA exonucleases (such as SbcB, SbcCD and RecJ), or be 
filled by polymerases, to create an appropriate template for RecBCD. Once 
RecBCD is bound to a free DNA end, it translocates along and unwinds the 
duplex, and at the same time degrades both strands. RecB and RecD are both 
helicase motors, with RecD being generally faster. RecB also possesses 5 and 
3 ssDNA nuclease activities, but is most favourably positioned to cleave the 3 
ssDNA tail, and this strand is therefore hydrolysed much more vigorously than 
the 5 ssDNA tail (Figure 1-2 B). The unwind and degradation of both strands 
proceed until the RecBCD complex encounters a specific, properly oriented 
sequence, called Chi sequence (Crossover Hotspot Instigator, 5-GCTGGTGG-
3), or Ȥ (Sprague et al., 1978; Bianco and Kowalczykowski, 1997). This 
sequence is recognised and remains tightly bound by the RecC protein. This 
event prevents the exit of the 3 ssDNA strand from RecC and therefore halting 
its hydrolysis by RecB. At the same time the 5 ssDNA strand continues to exit 
and is cleaved more readily by RecB. This change of activity results in a 3 
ssDNA tail, a platform on which RecBCD then loads a RecA filament (Figure 
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1-2 C) (Dixon and Kowalczykowski, 1993; Anderson and Kowalczykowski, 
1997; Anderson and Kowalczykowski, 1997; Dillingham and 
Kowalczykowski, 2008). In this pathway, the ssDNA is never exposed to SSB.  
 
In addition to DSBs, RecA can also use ssDNA gaps, but only with the 
assistance of the RecFOR pathway, which can direct RecA to sites even if they 
are bound by SSB.  
1.3.2 The RecFOR pathway 
Under normal conditions, the RecFOR pathway promotes the repair at ssDNA 
gaps and is less active than the RecBCD pathway. However, in a nucleases 
depleted background, the RecFOR pathway is also able to process DSBs for 
loading RecA filament when the RecBCD pathway is not available (Ryder et 
al., 1996). In fact, the significance of the RecFOR pathway can be evaluated in 
terms of evolution. The existence of the RecBCD pathway is only restricted in 
Figure 1-2 Model for RecBCD enzyme mechanism (Dillingham and Kowalczykowski, 2008). 
The three subunits are colour coded as described above, with important functional regions in 
the structure also labelled. 
A. initiation complex B. pre-Chi recognition C. post-Chi recognition 
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a few species, whereas RecFOR (in some species RecF or RecO or both are 
missing) are almost as ubiquitous as the RecA protein (Rocha et al., 2005). 
Unlike RecBCD working as a single complex, RecR forms a complex either 
with RecF or with RecO, but not with both at the same time (Webb et al., 1997; 
Morimatsu and Kowalczykowski, 2003). RecF is a DNA binding protein, with 
increased affinity for dsDNA (Umezu and Kolodner, 1994; Webb et al., 1995; 
Webb et al., 1997). RecO binds both dsDNA and ssDNA, and is able to anneal 
complementary oligonucleotides and catalyse invasion of duplex DNA by a 
complementary ssDNA (Luisi-DeLuca and Kolodner, 1994; Kantake et al., 
2002). The E. coli RecR protein does not possess any enzymatic or DNA 
binding activities, but it increases the affinity of both RecO and RecF for DNA 
when complexed with them (Umezu and Kolodner, 1994; Webb et al., 1995; 
Webb et al., 1997). In a classic RecFOR pathway, the RecFR complex 
probably defines regions for loading of the RecA filament by binding to 
dsDNA-ssDNA junctions (Sakai and Cox, 2009). Presumably, this activity not 
only facilitates the initiation of RecA nucleation on ssDNA gaps coated by 
SSB (Morimatsu and Kowalczykowski, 2003), but also inhibits the extension 
of RecA filament to dsDNA (Webb et al., 1997). In this context, RecO is also 
required to act in concert with RecFR (Makharashvil et al., 2009; Sakai and 
Cox, 2009). However, RecFR was found to bind randomly on dsDNA, with no 
enhanced affinity to dsDNA-ssDNA junctions. An unknown factor is thus 
required to guide RecFR (Figure 1-3).  
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Recent studies have revealed that RecOR is able to mediate RecA loading 
through an alternative pathway. When there is no proximal duplex, RecOR can 
facilitate nucleation of RecA filaments onto SSB-coated ssDNA  (Sakai and 
Cox, 2009). RecF is dispensable in this pathway. 
In conclusion, the RecFOR proteins are able to load RecA to ssDNA even 
when it is protected by SSB. This poses a constant threat in that RecA may 
initiate recombination when it is not required, which is sometimes even 
dangerous. 
 
 
Figure 1-3 Model for RecFOR function on gapped DNA (Sakai and Cox, 2009). An unknown 
factor (X) is required to recognise the dsDNA-ssDNA junction and guide RecFR to the 
junction for loading of RecA. This process also requires RecO.
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1.4 RecA can be toxic 
There is growing evidence that a number of factors have evolved to limit 
recombination in a variety of ways. 
1) Remove RecA from ssDNA. UvrD is one of the proteins mediating this 
strategy (Morel et al., 1993; Veaute et al., 2005; Lestini and Michel, 
2007). The UvrD protein is a 3-5 helicase, and is typically required 
for NER and MMR (Kuzminov, 1999; Matson and Robertson, 2006). 
2) Destabilise RecA-ssDNA filament. The RecX protein falls into this 
category with its ability of capping the RecA-DNA filament, thus 
preventing its extension (Drees et al., 2004; Lusetti et al., 2004a; 
Lusetti et al., 2004b).  
3) Avoid exposing ssDNA unnecessarily. Although it is largely achieved 
by SSB, recent researches suggested PriA and Rep act in a different 
manner but with a similar effect. PriA is a DNA replication restart 
protein; the role of Rep is not clear, but is thought to assist replication 
fork progression (Lane and Denhardt, 1975; Yancey-Wrona and 
Matson, 1992) and to function in a PriA independent, PriC-Rep 
replication restart pathway (Sandler, 2000). Both PriA and Rep have 3-
5 helicase activity and are able to unwind the lagging strand at a stalled 
replication fork, thus retrieving any possible exposed ssDNA at the 
leading strand (Figure 1-4) (Mahdi et al., 2006).   
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A number of genetic models fit with the idea that recombination can be toxic. 
In the absence of UvrD, recombination is enhanced and leads to a requirement 
for RuvABC to maintain viability (Magner et al., 2007), unless RecA or 
RecFOR are eliminated. A similar situation has been observed through studies 
of interactions between mutations in priA, rdgC and dnaC. 
Strains carrying null mutations in priA have much reduced viability, are highly 
sensitive to DNA-damaging agents and are defective in recombination (Nurse 
et al., 1991; Kogoma et al., 1996). This phenotype is presumably a reflection of 
the failure to promote replication restart when forks encounter lesions in the 
DNA (Liu and Marians, 1999). It can be suppressed by mutations in dnaC, the 
product of which normally binds the DnaB replicative helicase, directing its 
loading onto DNA to initiate replication at oriC, or to allow replication restart 
for repair or rescue of damaged or blocked forks.  
Studies by Sandler and co-workers revealed that the priA dnaC strains rely on 
the Rep helicase and PriC protein to maintain viability (Sandler, 2000). This 
was certainly true of the dnaC809 suppressor (encoding the same substitution 
Figure 1-4 A model for how 3-5 helicase activity of Rep may unwind the lagging strand and close the 
leading strand gap (the left pathway) to prevent otherwise potentially lethal activity of RecA initiated by 
RecFOR (the right pathway) (Mahdi et al., 2006). Flips mark the 3 ends. 
RecFOR (-Rep) Rep 
SSB 
RecA 
Replication fork rescue Recombination 
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in DnaC as dnaC810). The Rep protein was thought to provide an alternative 
helicase activity that could create a loading pad for DnaB in the absence of 
PriA helicase activity. PriC is now known to provide an alternative means for 
loading DnaB (Heller and Marians, 2007). However, further studies by Sandler 
identified a dnaC super-suppressor, dnaC809,820, carrying a second 
substitution that eliminated the requirement for Rep and PriC (Sandler, 2000).  
The inactivation of rdgC confers no obvious phenotype in otherwise wild type 
cells (Ryder et al., 1996). However, it eliminates the residual viability of priA 
null cells (Moore et al., 2003) and curtails severely the ability of dnaC 
mutations to suppress the priA phenotype (Moore et al., 2003). 
dnaC212 is another dnaC mutation that can suppress the phenotype of a priA 
null strain. It was isolated by A. V. Gregg in the Lloyd laboratory (Gregg et al., 
2002) and studied by Moore and colleagues (Moore et al., 2003). It was 
discovered that indeed priA- dnaC212 rdgC- strains grew very slowly and 
readily developed suppressors, which included mutations inactivating or 
modifying SSB, RecO and RecF (Moore et al., 2003). This observation 
provided the first hint that RdgC might act to limit unnecessary recombination 
via RecFOR mediated loading of RecA. 
These data point strongly to the idea that RdgC acts in some way to limit RecA 
activity, and is crucial when the PriC pathway is inactivated in a priA- 
dnaC809,820 background. This possibility was further supported when a 
deletion of rdgC was introduced into priA-, priA- dnaC810, priA- dnaC809,820 
and priA- dnaC809,820 priC- strains, using synthetic lethality construct 
carrying an unstable plasmid with priA+ and lac+. Viability of the plasmid free 
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segregants is revealed when lac- (white) colonies are produced on agar plates 
supplemented with X-gal and IPTG (Mahdi et al., 2006). This study confirmed 
that priA- rdgC- cells are inviable (Figure 1-5 N6040). Deletion of rdgC also 
conferred inviability on a priA- dnaC810 strain (Figure 1-5 N6111), but not on 
a priA- dnaC809,820 strain (Figure 1-5 N6457), unless PriC was missing 
(Figure 1-5 N6538). Furthermore, viability could be restored to a priA- 
dnaC810 rdgC
- strain by eliminating recA (Figure 1-5 N6157). 
 
1.5 RdgC  
The rdgC gene was discovered in 1985 in an attempt to screen for the sbcCD 
gene (Lloyd and Buckman, 1985). RdgCs involvement in DNA recombination 
became clear first in 1996. Ryder and colleagues found that in strains lacking 
nucleases, deletion of rdgC made the cells growth dependent on the remaining 
recombination activity (Ryder et al., 1996). Its high expression level during 
exponential phase (~1000 molecules per cell) provided another piece of 
evidence for its interaction with DNA metabolism (Moore et al., 2003). In vitro 
studies then revealed that RdgC is a DNA binding protein (Moore et al., 2003). 
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N5936 
N5972 N6021 N6445 N6471 
N6040 N6111 
N6157 
N6538 N6457 
priA+/MG1655 
priA+/¨priA priA+/¨priA dnaC810 
priA+/¨priA 
dnaC809,820 
priA+/¨priA 
dnaC809,820 ¨priC
priA+/¨priA ¨rdgC 
priA+/¨priA 
dnaC810 ¨rdgC
priA+/¨priA 
dnaC809,820 ¨rdgC 
priA+/¨priA ¨priC 
dnaC809,820 ¨rdgC
priA+/¨priA ¨recA 
dnaC810 ¨rdgC
-priA 
dnaC810 
-rdgC -rdgC -rdgC -rdgC 
-recA 
dnaC820 -priC 
Figure 1-5 Synthetic lethality assays presenting situations where deletion of rdgC could have an effect (R. 
G. Lloyd, unpublished data). Details about how synthetic lethality assay is conducted can be found in 
Mahdi et al., 2006. 
Cells lacking PriA are sick (N5972). It can be overcome by dnaC810 (N6021) and dnaC810, 820 (N6445). 
dnaC810 is a weak suppressor of ¨priA, as deletion of rdgC is synthetic lethal with ¨priA dnaC810 
(N6111). This can be overcome either by an additional mutation on dnaC to form dnaC810, 820 (N6457), 
or deletion for recA (N6157). With the strong suppressor (dnaC810, 820) of ¨priA, cells lacking PriA 
require either RdgC or PriC to sustain viability; the cells lacking both are not viable (N6538). 
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1.5.1 RdgC binds DNA 
The RdgC protein of Escherichia coli is a 34 kDa protein associated with the 
nucleoid (Ryder et al., 1996; Murphy et al., 1999). In solution, it presents in 
equilibrium as monomer, dimer and tetramer, with predominant presence as a 
dimer (Moore et al., 2003; Tessmer et al., 2005; Drees et al., 2006). 
Previous studies showed that RdgC is a DNA binding protein without any 
enzymatic activities (Moore et al., 2003). It appeared that RdgC binds DNA as 
a dimer (Moore et al., 2003). The dimer was able to bind all DNA structures 
tested with high affinity, including single stranded DNA, blunt duplex, flayed 
duplex, three-strand junction, Y-DNA and Holliday junction (Figure 1-6) 
(Moore et al., 2003). Interestingly, it exhibited a slight preference for dsDNA 
compared to ssDNA. Nonetheless, RdgC can still bind with high affinity to 
ssDNA when secondary structures (e.g. hairpin structures) are present (Moore 
et al., 2003; Drees et al., 2006). Atomic Force Microscopy studies showed an 
end preference of the protein, but this could not be confirmed by other 
experiments (Moore, 2002; Tessmer et al., 2005). The minimum lengths of 
DNA required for stable contact was also determined for both dsDNA (15 bp) 
and ssDNA (23 nt) (Moore, 2002).  
The dimer formation of the protein and its different affinity for dsDNA and 
ssDNA had implicated more than one DNA binding sites on RdgC. However, 
the competition assays by introducing poly(dIdC) as a competitor to 
RdgC:DNA complexes and AFM studies failed to detect a second binding site. 
The fact that all the DNA was in the form of the highest order complex when 
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sufficient concentrations of RdgC were used suggests RdgC can diffuse in one-
dimension along bound DNA (Moore, 2002). 
 
 
Figure 1-6 Gel assays showing DNA binding activity of RdgC. Binding reactions contained 
0.1 nM DNA species, (i) 61 nucleotide ssDNA, (ii) 61 bp dsDNA, (iii) flayed duplex, (iv) 
three-strand junction, (v) Y-DNA, (vi) Holliday junction J12, and RdgC at 0, 0.5, 5, 50 and 500 
nM in lanes a-e, f-j and k-o, respectively. (Moore et al., 2003) 
 
1.5.2 RdgC limits RecA activities in vitro 
How does RdgC DNA binding limit RecA activities? Drees and colleagues 
conducted a series of in vitro experiments in an attempt to answer this question 
(Drees et al., 2006). The RecA filament is most stable when bound to ssDNA. 
This stability decreases when RecA filament is on dsDNA. Although RdgC can 
bind to ssDNA, its affinity is not high enough for the protein to displace bound 
RecA. An effective inhibition was only seen when excess RdgC was added 
prior to the addition of RecA to saturate all ssDNA molecules. This is also 
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partially due to its high affinity for ssDNA secondary structures. On the other 
hand, its higher affinity for dsDNA compared to that of RecA enabled RdgC to 
effectively protect the covered dsDNA from being invaded by RecA:ssDNA 
filaments. RdgC can even displace RecA proteins that are bound to dsDNA. 
This re-enforces the idea that the function of RdgC is to prevent or limit 
unnecessary recombination, by competing for common substrates (Drees et al., 
2006). However, given the limited number of RdgC compared to available 
dsDNA sites that it could bind, it would be almost impossible for RdgC to 
protect dsDNA from illegitimate recombination if it binds randomly along the 
chromosome. It has also been proposed that some proteins might act as a guide 
to direct RdgC. Indeed, several proteins were reported to be able to interact 
with RdgC in an attempt to reveal protein interactions among essential and also 
non-essential proteins in E. coli (Butland et al., 2005), including the products 
of ligA, huB, and nfi; but the interactions have not been proved to be genuine 
and could be mediated by DNA (all the proteins bind to DNA).  
It has also been proposed that RdgC might function in different ways as 
monomers, dimers or tetramers. Disagreeing with Moore et al (2003) who did 
not observe any bimodal DNA bindings,  Drees et al (2006) showed that RdgC 
bound duplex DNA with higher affinity when protein concentrations were 
either low (10 nM-100 nM) or high (>1000 nM). When the protein 
concentrations dropped in between 100 nM and 1000 nM, the rate of increasing 
bound duplex was reduced. A similar effect was observed under certain 
conditions when RdgC was added after RecA protein was bound to ssDNA in 
the absence of SSB. The formation of RecA filaments was presumably 
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interrupted by regions of secondary structure in the ssDNA, which could be 
used by RdgC to inhibit RecA activities. This inhibitory effect was evident 
when RdgC was at low concentrations (0.2 to 0.4 ȝM) or high concentrations 
(4 to 16 ȝM). However, this effect was greatly lessened when the RdgC 
concentration was at 1 ȝM. Based on the data, Drees and colleagues suggested 
that RdgC has high affinity for dsDNA as monomer or tetramer, and this is 
when RdgC limits RecA activities by binding tightly to dsDNA; when RdgC is 
present as dimers, the inhibition is limited due to its weakened dsDNA binding 
(Drees et al., 2006). 
1.5.3 RdgC in vivo 
The idea that RdgC negatively regulates RecA activities by binding to DNA is 
becoming widely accepted. However, this role is not obvious in an rdgC single 
mutant. Strains deleted for rdgC do not show any evident defects in either cell 
growth or resistance to DNA damages (Ryder et al., 1996). Its in vivo 
interaction with recombination can only be investigated when normal 
recombinations of replication restart are compromised. 
As previously mentioned, cells lacking priA are very sick (Figure 1-3 N5972). 
Since the PriA protein plays a crucial role in DNA replication restart after 
replication forks abnormally collapse, this suggests such event commonly 
occurs even under normal growth conditions. Certain dnaC mutants such as 
dnaC810, dnaC212, and dnaC809,820 can suppress the loss of priA by actively 
using the PriC-Rep pathway for replication restart. However, all the viabilities 
more or less require the presence of RdgC, as discussed previously. For 
instance, priA- rdgC- and priA- dnaC810 rdgC-strains are dead (Moore et al., 
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2003); priA- dnaC212 rdgC- strains are very sick and readily develop 
suppressors (Moore et al., 2003); and priA- dnaC809,820 rdgC- has to rely on 
PriC for cells growth (Figure 1-3; R. G. Lloyd, unpublished data). The toxic 
effects of the RecFOR mediated loading of RecA have been confirmed at least 
in two of the situations: priA- dnaC810 rdgC- (Figure 1-3; R. G. Lloyd, 
unpublished data) and priA- dnaC212 rdgC- (Moore et al., 2003). In addition to 
recF, recO and recR, the suppressors for priA- dnaC212 rdgC- also included 
mutations on ssb and rpoB. The C-terminus of SSB is known to interact with 
many proteins, including RecO (Hobbs et al., 2007) and PriA (Cadman and 
McGlynn, 2004). Some SSB C-terminus mutants have been reported to 
perform much of the wild type function, but are resistant to RecFOR mediated 
loading of RecA. rpoB encodes the ȕ subunit of RNA polymerase, which 
attaches to DNA during transcription. This process is much slower than 
replication, potentially causing pathogenic encounter between transcription and 
replication. The mutations on rpoB presumably weaken the interaction between 
the RNA polymerase and the transcribing DNA, thus reducing the chance of 
halting replication forks (Moore, 2002). 
The interaction between RdgC and RecA is rather perplexing in strains lacking 
RecBCD and SbcBC. SbcB and SbcC digest exposed DNA ends and attack 
hairpin structures (Connelly and Leach, 1996), and is problematic when 
RecBCD is not available to process and protect DNA ends. The cells lacking 
both nuclease systems are as viable as the wild type. However, if the strain is 
further deprived of rdgC, the cells viability relies on the RecFOR pathway to 
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load RecA (Ryder et al., 1996). This indicates that RdgC acts in a pathway 
parallel to RecFOR in DNA maintenance. 
To sum up, RdgC is a DNA binding protein, without any preference for 
specific structures or sequences, although it binds dsDNA slightly better than 
ssDNA. This DNA binding protein is dispensable for cell growth under normal 
conditions, but plays a vital role to antagonise RecA toxicity when replication 
restart systems are compromised. The question is: how does RdgC achieve 
these effects?  I set out to try and answer this question by studying the structure 
of the protein and its mode of DNA binding. For this purpose, I purified the 
RdgC protein in large scale, and crystallised it with a variety of DNA 
substrates. Its crystal structure was resolved to 2.4 Å. Several rdgC mutants 
were constructed based on the structural information; and their in vivo 
synthetic lethality assays were combined with their gene products in vitro DNA 
binding analyses to elevate our knowledge to a new level on RdgCs role in 
DNA recombinational repair. 
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Chapter 2 
Materials and methods 
2.1 Materials 
2.1.1 Buffers and solutions 
All buffers and solutions are given as working concentrations. The 
concentration of the stock solution, when made, is detailed in parenthesis. After 
manufacture, buffers and solutions were sterilised either by autoclaving at 121 
ºC for 15 minutes, or by filtering through a Whatman 0.45 ȝm filter where 
necessary. 
All buffers used in this work are listed below: 
TBE  90 mM Tris-borate, 1 mM EDTA (stock solution, 10×) 
GBB (Gel Binding Buffer)  50 mM Tris·HCl pH8.0, 100 ȝg/ml BSA, 2 mM 
MgCl2, 6% (v/v) glycerol, 1 mM DTT (stock solution, 5×) 
LIS (Low Ionic Strength)  6.7 mM Tris·HCl pH 8.0, 3.3 mM sodium acetate, 
2 mM MgCl2 (stock solution, 20×) 
MC buffer  100 mM MgSO4, 5 mM CaCl2 
SSC  150 mM MgCl2, 15 mM sodium citrate, pH 7.0 (stock solution, 20×) 
SDS PAGE running buffer  0.1% (w/v) SDS, 1.44% (w/v) glycine, 0.3% (w/v) 
Trizma base (stock solution, 10×) 
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SDS PAGE loading buffer  50 mM Tris·HCl pH 6.8, 100 mM DTT, 2% (w/v) 
SDS, 0.1% (w/v) bromphenol blue, 10% (v/v) glycerol (stock solution, 5×) 
Disruption buffer  50 mM Tris·HCl pH7.5, 1 mM EDTA, 1 mM DTT 
Buffer A  50 mM Tris·HCl pH 7.5, 1 mM EDTA, 1 mM DTT (10 mM DTT 
for purification of Seleno-methionine derivatives) 
Buffer B  20 mM Tris·HCl pH 7.5, 0.1 M NaCl (extra 2 mM DTT for 
purification of Seleno-methionine derivatives) 
2.1.2 Microbial growth media and supplements 
Yeast extract, tryptone and Bacto-agar were all obtained from Difco. Liquid 
and solid media used for the growth of E. coli were prepared according to the 
following standard recipes, and then sterilised by autoclaving at 121 ºC, for 15 
minutes. Media were supplemented with antibiotics as required. 
2.1.2.1 LB media 
LB (Luria-Burrous) broth contained 5 g/l yeast extract, 10 g/l tryptone, 0.5 g/l 
NaCl and 0.08 g/l NaOH made up in distilled water to a final pH 7.5. LB agar 
plates were supplemented with 15 g/l of Bacto-agar. 
2.1.2.2 Mu media 
Mu broth contained 5 g/l yeast extract, 10 g/l tryptone and 10 g/l NaCl made 
with distilled water to a final pH 7.5. Mu agar plates were supplemented with 
10 g/l Bacto-agar. Mu overlays were supplemented with either 4 or 6 g/l Bacto-
agar. 
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2.1.2.3 Minimal media 
Minimal 56/2 salts media (Willetts et al., 1969) contained 2.64 g/l KH2PO4, 4.3 
g/l Na2HPO4, 0.1 g/l MgSO4·7H2O, 0.1 g/l (NH4)2SO4, 0.005 g/l Ca(NO3)2 and 
0.0025 g/l FeSO4·7H2O in distilled water. For minimal salts solid media, 56/2 
salts were used at double strength and Bacto-agar added to 15 g/l. 56/2 salts 
media was further supplemented with thiamine (1 ȝg/ml), a carbon source 
(glucose (3.3 mg/ml) or maltose (3.3 mg/ml)) and any specific requirements as 
described below. 
2.1.2.4 Antibiotic solutions 
Antibiotic stocks were made in sterile distilled water unless otherwise stated. 
Stock solutions of the following were kept at 4 ºC: chloramphenicol (2 mg/ml), 
ampicillin (4 mg/ml), carbenicillin (4 mg/ml), kanamycin (4 mg/ml) and 
streptomycin (20 mg/ml). 3 ml aliquots of tetracycline (2 mg/ml) were stored at 
-20 ºC. Trimethoprim (1 mg/ml) and rifampicin (10 mg/ml) were dissolved in 
methanol and stored at -20 ºC. Antibiotics were used at the following working 
concentrations: 
Chloramphenicol 20 ȝg/ml 
Ampicillin  40 ȝg/ml 
Carbenicillin  40 ȝg/ml 
Kanamycin  25 ȝg/ml 
Streptomycin  100 ȝg/ml 
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Tetracycline  20 ȝg/ml 
Trimethoprim  20 ȝg/ml 
Rifampicin  10-100 ȝg/ml as indicated (e.g. Rif = 50 ȝg/ml) 
The antibiotics could be used on rich or minimal plates, with the exception of 
trimethoprim which is only selective on minimal plates. 
2.1.3 Strains, bacteriophages and plasmid used 
The E. coli strains used in this study are listed in Table 2.1, and plasmids in 
Table 2.2. Bacteriophage P1 vir was used in this study for transductions (Miller, 
1972). If derived in this work, the shorthand under source or reference in Table 
2.1 indicates the construction parameters, including the recipient strain, P1 
donor strain, type of selection and any other comments. 
¨rdgC::dhfr or ¨rdgC2::dhfr was introduced to replace the wild type rdgC in 
the chromosome. The replacing dhfr encodes resistance to trimethoprim, which 
was used to select rdgC- cells. rdgCmutant-cat was consequently engineered to 
replace ¨rdgC::dhfr or ¨rdgC2::dhfr. The cat gene immediately downstream of 
the linked alleles encodes resistance to chloramphenicol, which was used to 
select rdgCmutant cells. Details of the method can be found in section 2.2.9.  
Table2.1Strainsusedinthisstudy
Strain Relevantgenotype Sourceorreference
a)  MG1655 derivatives 
MG1655 wildtype1 (Bachmann,1996)
N4586 ѐrdgC::dhfr P1 ?JP947×MG1655toTmr
N5286 ѐxonA300::cat P1 ?STL2694×MG1655toCmr
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N5500 priA300 (Mahdietal.,2006)
N5521 priA300dnaC810zji ?202::Tn10 P1 ?DIM167×N5500toTcr
N5539 dnaC810zji ?202::Tn10priA2::kan P1 ?PN105×N5521toKmr
N5935 ѐpriA::apra Originalrecombineeringstrain
N5949 ѐpriA::apradnaC(unknown) UVrderivativeofN5935
YJ012 ѐrdgC::dhfrѐxonA300::cat P1 ?N5286×N4586toCmr
YJ015 ѐrdgC::dhfrѐxonA300::catpT7pol26 pT7pol26×YJ012toKmr
  
b)  AB1157 derivatives 
AB1157
2  (Bachmann,1996)
JP947 ѐrdgC::dhfr AgiftfromJoePeters
  
c)  TB28, F- (plasmid-free) derivatives 
TB28 ѐlacIZYA (BernhardtanddeBoer,2004)
AM1833 rdgCR118C ?cat Thiswork3
AM1834 rdgCP76G,L116T,ѐ(77 ?115) ?cat Thiswork
AM1835 rdgCP76G,L116T,ѐ(77 ?115),R118C ?cat Thiswork
AM1836 rdgCH222A ?cat Thiswork
AM1837 rdgCK227A ?cat Thiswork
AM1838 rdgCR118A ?cat Thiswork
AM1839 rdgCK211A ?cat Thiswork
AM1840 rdgCE218R ?cat Thiswork
AM1887 rdgCwt ?cat Thiswork
AM1905 rdgCF120T ?cat Thiswork
AM1917 rdgCF120S ?cat Thiswork
AM1929 ѐrdgC2::dhfr4 Thiswork
AM1931 N.rdgC ?cat Thiswork
AM1950 rdgCR97S,K98Q,K100Q,K101E ?cat Thiswork
AM2029 rdgCQ212A ?cat Thiswork
YJ025 rdgCR118C,F120T ?cat Thiswork
  
d)TB28,pAM374(pRC7,priA+)derivatives
N5936 ѐlacIZYA (Mahdietal.,2006)
N5972 ѐpriA::apra P1 ?N5949×N5936toAprar
N6021 ѐpriA::apradnaC810zji ?202::Tn10 P1 ?N5539×N5972toTcr
N6040 ѐpriA::apraѐrdgC::dhfr P1 ?N4586×N5972toTmr
N6111 ѐpriA::apradnaC810zji ?202::Tn10ѐrdgC::dhfr P1 ?N4586×N6021toTm
r
N6131 priA2::kandnaC810zji ?202::Tn10 P1 ?PN105×N6021toKmr
N6143 priA2::kandnaC810zji ?202::Tn10ѐrdgC::dhfr P1 ?N4586×N6131toTm
r
N6157 priA2::kandnaC810zji ?202::Tn10ѐrdgC::dhfrѐrecA::apra P1 ?N6124×N6143toApra
r
N6445 ѐpriA::apradnaC809,820zji ?202::Tn10 P1 ?N6424×N6021toTcr
N6457 ѐpriA::apradnaC809,820zji ?202::Tn10 P1 ?N4586×N6445toTmr
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ѐrdgC::dhfr
N6471 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kan P1 ?N6424×N6445toKm
r
N6538 ѐpriA::apradnaC809,820zji ?202::Tn10ѐrdgC::dhfrpriC303::kan P1 ?N6424×N6457toKm
r
AM1843 ѐpriA::aprardgCR118C ?cat P1 ?AM1833×N5972toCmr
AM1844 ѐpriA::aprardgCP76G,L116T,ѐ(77 ?115) ?cat P1 ?AM1834×N5972toCmr
AM1845 ѐpriA::aprardgCP76G,L116T,ѐ(77 ?115),R118C ?cat P1 ?AM1835×N5972toCmr
AM1846 ѐpriA::aprardgCH222A ?cat P1 ?AM1836×N5972toCmr
AM1847 ѐpriA::aprardgCK227A ?cat P1 ?AM1837×N5972toCmr
AM1848 ѐpriA::aprardgCR118A ?cat P1 ?AM1838×N5972toCmr
AM1850 ѐpriA::aprardgCE218R ?cat P1 ?AM1840×N5972toCmr
AM1853 ѐpriA::apradnaC810zji ?202::Tn10
rdgCR118C ?cat P1 ?AM1833×N6021toCm
r
AM1854 ѐpriA::apradnaC810zji ?202::Tn10
rdgCP76G,L116T,ѐ(77 ?115) ?cat P1 ?AM1834×N6021toCm
r
AM1855 ѐpriA::apradnaC810zji ?202::Tn10
rdgCP76G,L116T,ѐ(77 ?115),R118C ?cat P1 ?AM1835×N6021toCm
r
AM1856 ѐpriA::apradnaC810zji ?202::Tn10
rdgCH222A ?cat P1 ?AM1836×N6021toCm
r
AM1857 ѐpriA::apradnaC810zji ?202::Tn10
rdgCK227A ?cat P1 ?AM1837×N6021toCm
r
AM1858 ѐpriA::apradnaC810zji ?202::Tn10
rdgCR118A ?cat P1 ?AM1838×N6021toCm
r
AM1860 ѐpriA::apradnaC810zji ?202::Tn10
rdgCE218R ?cat P1 ?AM1840×N6021toCm
r
AM1911 ѐpriA::aprardgCF120T ?cat P1 ?AM1905×N5972toCmr
AM1912 ѐpriA::apradnaC810zji ?202::Tn10
rdgCF120T ?cat P1 ?AM1905×N6021toCm
r
AM1913 ѐpriA::apraN.rdgC ?cat P1 ?AM1931×N5972toCmr
AM1914 ѐpriA::apradnaC810zji ?202::Tn10N.rdgC ?
cat P1 ?AM1931×N6021toCm
r
AM1918 ѐpriA::apraѐrdgC2::dhfr P1 ?AM1929×N5972toTmr
AM1919 ѐpriA::apradnaC810zji ?202::Tn10ѐrdgC2::dhfr P1 ?AM1929×N6021toTm
r
AM1935 ѐpriA::aprardgCK211A ?cat P1 ?AM1839×AM1918toCmr
AM1936 ѐpriA::apradnaC810zji ?202::Tn10
rdgCK211A ?cat P1 ?AM1839×AM1919toCm
r
AM1948 ѐpriA::aprardgCR97S,K98Q,K100Q,K101E ?cat P1 ?AM1950×AM1918toCmr
AM1949 ѐpriA::apradnaC810zji ?202::Tn10
rdgCR97S,K98Q,K100Q,K101E ?cat P1 ?AM1950×AM1919toCm
r
AM1963 ѐpriA::aprardgCF120S ?cat P1 ?AM1917×AM1918toCmr
AM1964 ѐpriA::apradnaC810zji ?202::Tn10
rdgCF120S ?cat P1 ?AM1917×AM1919toCm
r
AM2046 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCwt ?cat P1 ?AM1887×YJ026toCm
r
AM2048 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCK227A ?cat P1 ?AM1837×YJ026toCm
r
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AM2049 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCR118A ?cat P1 ?AM1838×YJ026toCm
r
YJ026 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanѐrdgC2::dhfr P1 ?AM1929×N6471toCm
r
YJ027 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCK211A ?cat P1 ?AM1839×YJ026toCm
r
YJ028 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCQ212A ?cat P1 ?AM2029×YJ026toCm
r
YJ029 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCE218R ?cat P1 ?AM1840×YJ026toCm
r
YJ030 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCH222A ?cat P1 ?AM1836×YJ026toCm
r
YJ033 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCR118C ?cat P1 ?AM1833×YJ026toCm
r
YJ034 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCP76G,L116T,ѐ(77 ?115) ?cat P1 ?AM1834×YJ026toCm
r
YJ035 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCP76G,L116T,ѐ(77 ?115),R118C ?cat P1 ?AM1835×YJ026toCm
r
YJ036 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCF120T ?cat P1 ?AM1905×YJ026toCm
r
YJ037 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCF120S ?cat P1 ?AM1917×YJ026toCm
r
YJ038 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCR97S,K98Q,K100Q,K101E ?cat P1 ?AM1950×YJ026toCm
r
YJ039 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanrdgCR118C,F120T ?cat P1 ?YJ025×YJ026toCm
r
YJ040 ѐpriA::apradnaC809,820zji ?202::Tn10
priC303::kanN.rdgC ?cat5 P1 ?AM1931×YJ026toCm
r
YJ041 ѐpriA::aprardgCQ212A ?cat P1 ?AM2029×AM1918toCmr
YJ043 ѐpriA::aprardgCR118C,F120T ?cat P1 ?YJ025×AM1918toCmr
YJ044 ѐpriA::apradnaC810zji ?202::Tn10
rdgCQ212A ?cat P1 ?AM2029×AM1919toCm
r
YJ046 ѐpriA::apradnaC810zji ?202::Tn10
rdgCR118C,F120T ?cat P1 ?YJ025×AM1919toCm
r
YJ047 ѐpriA::aprardgCwt ?cat P1 ?AM1887×AM1918toCmr
YJ048 ѐpriA::apradnaC810zji ?202::Tn10
rdgCwt ?cat P1 ?AM1887×AM1919toCm
r
  
e)BL21(DE3)derivatives
BL21(DE3) F ?ompThsdSB(rB ?mB ?)galdcm(DE3)pLysS (StudierandMoffatt,1986)
YJ014 ѐrdgC::dhfr P1 ?N4586×BL21(DE3)toTmr
  
f)Otherstrains
DIM167 DM4000
6priA2::kandnaC810zji ?
202::Tn10 (Moore,2002)
N5946 DM4000priC303::kanpriB202
dnaC809,820 AgiftfromSteveSandler
N6419 dnaC809,820zji ?202::Tn10 T.Moore,unpublished
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N6424 priC303::kanpriB202dnaC809,820zji ?
202::Tn10 P1 ?N6419×N5946toTc
r
PN105 priA2::kansulA AgiftfromKenMarians
STL2669 (ѐrecA ?srlR)306::Tn10,xonA2 AgiftfromSusanLovett
STL2694
ѐxonA300::catthr ?1leuB6proA2supE44
kdg51rfbD1araC14lacY1galK2xyl ?5mtl ?
1tsx ?33rpsL31rac ?
(ViswanathanandLovett,1998)
W3110 wildtype (Bachmann,1996)
  
1 F- Ȝ- ilvG- rfb-50 rph-1. MG1655 is the wild type K-12 strain used in this study 
2 F- Ȝ- rac- thi-1 hisG4 ¨(gpt-proA)62 argE3 thr-1 leuB6 kdgK51 rfbD1 araC14 lacY1 
galK2 xylA5 mtl-1 tsx-33 supE44(glnV44) rpsL31 (strR) 
3  From recombineering of rdgC in TB28 pKD46 (see methods section 2.2.9) 
4 ¨rdgC2::dhfr is total deletion of rdgC, whilst ¨rdgC::dhfr is partial deletion of rdgC. 
5 rdgC cloned from Neisseria meningitidis, a gift from Tom Baldwin, of the 
Meningococcal Virulence and Vaccine Development Group, Nottingham 
6 E. coli B F- ¨(pro-lac)X111 hisG4 argE3 thr-1 ara-14 xyl-5 mtl-1 rpsL31 sfiA::Mu-d(Ap, 
lac, B::Tn9) (Sandler, 1996) 
 
The plasmids used in this study were constructed from pRC7, pET22b and 
pT7-7 (Table 2.2). 
Table2.2Plasmidsusedinthisstudy
Name Description Sourceorreference
pRC7  (BernhardtanddeBoer,2004)
pAM374 priA+ (Mahdietal.,2006)
  
pKD46 Temperaturesensitiveplasmidat37°C
andencodingphageʄRedrecombinase
(DatsenkoandWanner,2000)
  
pT7 ?7 (TaborandRichardson,1985)
pGS853 rdgCwt (Mooreetal.,2003)
pGB043 rdgCP76G,L116T,ѐ(77 ?115) Thiswork*
pGB045 rdgCR118C Thiswork
pGB046 rdgCP76G,L116T,ѐ(77 ?115),R118C Thiswork
pGB049 rdgCR118A Thiswork
pGB051 rdgCF120S Thiswork
pGB053 rdgCF120T Thiswork
pGB055 rdgCR97S,K98Q,K100Q,K101E Thiswork
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pYJ003 rdgCH222A Thiswork
  
pET22b  Novagen
pYJ001 rdgCwt Thiswork
pGB047 rdgCR118C NdeI ?HindIIIfragmentfrom
pGB045
pGB048 rdgCP76G,L116T,ѐ(77 ?115),R118C NdeI ?HindIIIfragmentfrom
pGB046
pGB050 rdgCR118A NdeI ?HindIIIfragmentfrom
pGB049
pGB052 rdgCF120S NdeI ?HindIIIfragmentfrom
pGB051
pGB054 rdgCF120T NdeI ?HindIIIfragmentfrom
pGB053
pGB056 rdgCR97S,K98Q,K100Q,K101E NdeI ?HindIIIfragmentfrom
pGB055
pGB065 rdgCR119C,F120T Thiswork
pYJ007 rdgCK227A Thiswork
pYJ006 rdgCH222A NdeI ?HindIIIfragmentfrom
pYJ003
pYJ013 rdgCE218R Thiswork
pYJ014 rdgCK211A Thiswork
pYJ017 rdgCQ212A Thiswork
  
pLysS ExpressesT7lysozyme,Cmr Stratagene
pT7Pol26 ExpressesT7polymerase,Kmr (Mertensetal.,1995)
  
* Construction of these plasmids are detailed in section 2.2.7 
 
 
2.1.4 Oligonucleotides 
DNA oligonucleotides were synthesised by phosphoramidite chemistry and 
prepared by MWG. They were supplied lyophilised, and required no further 
purification when used to prime PCR. When used in EMSAs, they were 
purified on a sequencing gel beforehand. The oligonucleotides used in this 
study are listed below. 
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Table2.3Oligonucleotides
Name Sequence53 Length
(nt)
YJ1 AATGTAATCGTCTATGACGTT 21
YJ2 AACGTCATAGACGATTACATT 21
YJ3 GTAATCGTCTATGACGTT 18
YJ4 AACGTCATAGACGATTAC 18
YJ5 ATCGTCTATGACGTT 15
YJ6 AACGTCATAGACGAT 15
YJ7 TGTAATCGTCTATGACGTT 19
YJ8 AACGTCATAGACGATTACA 19
YJ9 TAATCGTCTATGACGTT 17
YJ10 AACGTCATAGACGATTA 17
YJ11 TGTAATCGTCTATGACGTTTTTTAACGTCATAGACGATTACA 42
YJ12 TAATCGTCTATGACGTTTTTTAACGTCATAGACGATTA 38
YJ13 GCTTCAATGTGATTGGTGATGCGTTCGCTGGTCAGATCTTGTTTC 45
YJ14 GAAACAAGATCTGACCAGCGAACGCATCACCAATCACATTGAAGC 45
YJ17 CACTTTTCCGGCTTCAATGGCATTGGTGATCTCTTCGC 38
YJ18 GCGAAGAGATCACCAATGCCATTGAAGCCGGAAAAGTG 38
YJ19 GCCAGTTTAGTCACCACTGCTCCGGCTTCAATGTG 35
YJ20 CACATTGAAGCCGGAGCAGTGGTGACTAAACTGGC 35
YJ21 GCTGGTCAGATCTTGTGCCTTCGCGCGGATCAC 33
YJ22 GTGATCCGCGCGAAGGCACAAGATCTGACCAGC 33
YJ23 GAGAAGCTTACGTTGTGCTTCGCCACC 27
YJ24 GGAGATATACATATGCTGTGG 21
YJ25 GGAAGGGCATATGTGGTTCAAAAATTTAATGACTTA 36
YJ26 CACAAGCTTATAATCTCGCTTTTTCGCCAC 30
YJ27 GTTAGCAGCCGGATCCTCAGTG 22
YJ28 CGTTATCATGCCCGCTAAATTTAACGACAAGGCCGTGGAAATTATCATGT
GGTTCAAAAATTTAATG
67
YJ29 CTTCGCTGGTCAGATCTGCTTTCTTCGCGCGGATC 35
YJ30 GATCCGCGCGAAGAAAGCAGATCTGACCAGCGAAG 35
TMRC1 TGACCTCGTCCAGTTCACG 19
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TMRC1R CGTGAACTGGACGAGGTCA  19
TMRC1 ?MM1 TGACCTCGTACAGTTCACG 19
TMRC1 ?MM3 TGACCTCGAAAAGTTCACG 19
TMRC1R ?D1 CGTGAACTGACGAGGTCA 18
TMRC2 ?DUMB CAGTTCACGTTTTCGTGAACTGGACGAGGTCTTTTGACCTCGTC 44
TMRC3 ?DUMB CCGGTCACGTTTTCGTGACCGGGCCGAGGTCTTTTGACCTCGGC 44
RGL13 GACGCTGCCGAATTCTGGCTTGCTAGGACATCTTTGCCCACGTTGACCC 49
RGL17 GGGTCAACGTGGGCAAAGATGTCCTAGCAAGCCAGAATTCGGCAGCGT
C
49
GB ?P29 GTTATCTGCGCGCGCAAAGAAGAAAAAATCCTCGGTACCGGC 42
GB ?P30 GCCGGTACCCCGCGTGCTTTCAGCCGTTTTAGCCAG 36
GB ?P31 CAAATTGTTATCTGCGCGCGCAAAGAAGAAAAAGGTACCCCG 42
GB ?P32 GCCGGTACCTTCAGCCGTTTTAGCCAGACAATGATGTGGATCG 43
GB ?P34 CGGCTGAAAGCACACGGCAGCAGAGA 26
GB ?P35 CGGCTGAAAGCACACGGGGTACCGAG 26
GB ?P37 TTTTAGCCAGACAATGATGTGGATCGACACGG 32
GB ?P41 CGGCAGCAGAGAGTGCAGCACTTCGTCTTTCAGC 34
GB ?P42 GCGGCTTTCAGCCGTTTTAGCCAGACAATGATGTGGATCG 40
GB ?P45 CTAGCAGCCGTTTTAGCCAGACAATGATGTGGATCG 36
GB ?P46 CACGCGGCAGCAGAGAGTGCAGCACTTCG 29
GB ?P47 GTCCCGTTTTAGCCAGACAATGATGTGGATCGACACGG 38
GB ?P48 GTCGCACGCGGCAGCAGAGAGTGCAGC 27
GB ?P51 CGATCTGCAGCTGACTCGCCTGTTCC 26
GB ?P52 CGGCCTGCAGGAAACCGAAAAAGATTCGC 29
GB ?P77 CGACTCACTATAGGGAGACCACAACGG 27
GB ?P78 GGGACGTCGCACACGGCAGCAGAGAGTGC 29
RdgC/Nm ?5 CGTTATCATGCCCGCTAAATTTAACGACAAGGCCGTGGAAATTATCATGT
GGTTCAAGCAGATTAG
66
Pro/rdgC ?5 ATCATGCCCGCTAAATTTAACGACAAGGCCGTGGAAATTATCATGCTGT
GGTTCAAAAATTTA
63
Tm/rdgC ?5 ATCATGCCCGCTAAATTTAACGACAAGGCCGTGGAAATTATCTGCAAGC
AGGATAGACGGC
61
Tm/rdgC ?3 ACGCGGCAGGCGTCGCATCCGGCATTAAAGGAAAATCAGCAATCAGCA
TCCAATGTTTCCG
61
RdgC/Cm ?3 GCCTGGTGTGGCTTCGTACGCCGGATAAGACGCGGCAGGCGTCGATCT
CAAGAAGATCATCTT
63
  
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2.2 Methods 
2.2.1 Growth of bacterial strains 
2.2.1.1 Solid media 
Agar plates were dried for 10-15 minutes at 70 ºC in a Leec drying cabinet 
prior to use. To obtain single colonies, inocula of a strain were streaked on the 
surface of a plate with a Tungsten loop, which was sterilised by heating to 
incandescence in a Bunsen flame. For precise amounts, samples from liquid 
cultures were pipetted directly onto the surface. For analysing a large number 
of strains simultaneously, cells were inoculated in regular arrays with a 
platinum tip (gridded). After 8-12 hours growth, the grids were replicated onto 
suitable test plates by adherence to a sterile velvet. Plates were incubated in a 
Leec incubator at 37 ºC, or as indicated. 
2.2.1.2 Liquid media 
Primary overnight cultures for routine use were prepared by suspending a 
single colony in 5 ml of LB broth in 15 ml screw capped tubes. Cultures were 
typically grown at 37 ºC overnight in a Leec incubator, with gentle rotation. 
Strains were stored like this for up to two weeks at 4 ºC. For long term storage, 
2.5 ml fresh overnight culture was mixed with 1.5 ml 80% glycerol and stored 
at -20 ºC. 
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2.2.2 Manipulation of bacterial strains 
2.2.2.1 Transfer of mutations by P1 transduction 
Phage P1 vir stocks were grown on the appropriate donor strain and used to 
transduce the selected marker into the desired recipient strains. Phage stocks 
were made by adding 107-108 plaque forming units (pfu) from a wild type 
strain (usually P1·W3110) into pre-incubated host strains in 8 ml Mu broth 
with A650 of 0.3 to 0.4. Host strains were treated with 0.1 ml 0.5 M CaCl2 for 5 
minutes prior to the addition of the phage. The cultures were incubated at 37 ºC 
with vigorous shaking until lysis was appropriate (denoted by slight clearing 
and flocculation). The remnant cells were treated by adding 0.5 ml chloroform. 
The lysates were then centrifuged at 10,000 rpm for 15-20 minutes at 4 ºC in 
15 ml Corex glass tubes. The supernatant having the phage was transferred into 
sterile culture tubes with 0.5 ml chloroform, and stored at 4 ºC. 8 ml 
experimental cultures of recipient strains were grown by diluting overnight 
cultures approximately 20 fold into fresh Mu broth supplemented with 
antibiotics needed and incubated at 37 ºC in a shaking water bath (Grants 
Instruments) with vigorous aeration to an A650 of 0.6. The cells were then 
pelleted by centrifugation and resuspended in 2 ml MC buffer (100 mM 
MgSO4, 5 mM CaCl2). 0.2 ml samples of the cells were then mixed with 50-
200 ȝl of phage P1 vir grown on the appropriate donor strains and the mixture 
incubated for 20-25 minutes at 37 ºC before adding 0.2 ml 1 M NaCitrate to 
prevent further phage infection. For transduction of antibiotic resistance 
markers, the transduced cells were mixed with 2.5 ml molten 0.6% overlay 
agar and plated directly on suitable selection plates. The plates were typically 
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incubated at 37 ºC for 24-72 hours. For linked markers, the transductants were 
gridded onto LB plates as described, and the resulting array was screened for 
segregation of the relevant genotype. Transductants were then purified on 
selective plates and used to make overnight cultures. The genotype of the 
transduced strain was verified by diagnostic plate tests and by PCR mediated 
sequencing where necessary. 
2.2.2.2 Transformation of plasmids 
Heat shock transformation 
E. coli cells to be transformed with plasmid DNA were grown to an A650 of 0.6 
in 8 ml of LB broth. Cells were harvested by centrifugation in an SS34 rotor at 
6000 rpm, 4 ºC for 10 minutes and resuspended in 1 ml 0.1 M CaCl2 on ice. 
200 ȝl of these cells were added to plasmid DNA as required and incubated on 
ice for 20 minutes. The mix was then heat shocked in a 42 ºC water bath for 2 
minutes and returned immediately to ice. 1 ml of LB buffer was added and the 
cells incubated at 37 ºC for 1 hour. The cells were harvested by high speed 
centrifugation in a benchtop centrifuge, resuspended in 100 ȝl LB broth and 
spread onto LB agar plates supplemented with appropriate antibiotic selection. 
Plates were then incubated at 37 ºC for overnight. 
Electroporation  
An overnight culture of the parental strain was diluted 1:100 in 50 ml of LB 
broth with an appropriate amount of ampicillin and IPTG. Cells were grown to 
an A650 of 0.8 and harvested after 15 minutes incubation on ice. The pellet was 
resuspended in ice-cold 1 mM HEPES buffer then centrifuged. This step was 
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repeated twice and the final pellet was resuspended in 1 mM HEPES buffer 
with 10% glycerol. Cell suspension was stored at -70 °C as 100 ȝl aliquots. 
1 ȝl of plasmid DNA was mixed with 40 ȝl of electrocompetent cells in an 
electroporation cuvette. Cells were pulsed at 1.8 kV and immediately recovered 
by adding 1 ml of SOC medium after electroporation. The mixture was 
transferred to a tube and recovered in a shaking water bath at 37 °C for 1 hour. 
Cells were collected and plated on appropriate selective plates. Next day 
colonies were collected in LB broth and mixed with 3 ml 80% glycerol per 5 
ml of cell suspension and stored at -20 °C. 
2.2.3 Assays on E. coli strains 
2.2.3.1 Checking strain genotypes 
It was often necessary to verify strain genotypes after transduction. When 
screening large numbers of candidates, e.g. moving linked genes, colonies were 
inoculated into regular arrays on a master plate, then replica plated using sterile 
velvets onto appropriate selection media. Patches displaying the required 
phenotype were purified from the master plate onto LB agar, grown as an 
overnight culture and re-tested. If fewer candidates required testing, e.g. after 
the inheritance of genes containing an antibiotic resistance marker, 2-10 ȝl of 
overnight culture was tested directly by streaking on the appropriate selection 
media. 
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2.2.3.2 Measuring sensitivity to DNA damage 
Semi-quantitative analysis of DNA damage sensitivity was achieved by 
streaking 10 ȝl of overnight culture onto LB agar supplemented with and 
without MC at 0.2 ȝg/ml or 0.5 ȝg/ml. A duplicate set was UV irradiated at a 
dose rate of 1 J/m2/sec, at a peak output of 245 nm, for 30 sec (MC containing 
plates) and 60 sec (LB agar only plates). Sensitivity to MC and UV was scored 
after overnight incubation, at 37 ºC, by comparing the growth of test strains to 
either a wild type, or parent, control strain. 
2.2.4 Preparation and analysis of DNA  
2.2.4.1 Extraction of plasmids  
Plasmid DNA was purified from overnight cultures of strains using either a 
Qiagen mini or midi prep kit. Cells were harvested by centrifugation and 
resuspended in 50 mM Tris·HCl, pH 8.0, 10 mM EDTA, 100 ȝg/ml RNase A. 
Cell lysis was performed by adding an equal volume of lysis solution (200 mM 
NaOH, 1% SDS) and allowing the reaction to proceed at room temperature for 
5 minutes. Addition of ~1.4 volumes of neutralisation buffer (3 M KAc, pH 
5.5), followed by centrifugation, separated cell debris and chromosomal DNA 
from the plasmid DNA. For the mini prep purification, the plasmid DNA was 
absorbed to a silica gel QIAprep column, washed with a high salt buffer to 
remove nuclease activity and a buffer containing 70% ethanol and then eluted 
with 30-50 ȝl of TE buffer. For the midi prep purification, the plasmid DNA 
was absorbed to a QIAgen tip column, equilibrated with 750 mM NaCl, 50 
mM MOPS, pH 7.0, 15% ethanol, 0.15% Triton X-100, prior to loading DNA 
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extract. The DNA was washed with a similar buffer, but containing 1M NaCl 
and eluted with 1.25 M NaCl, 50 mM Tris-HCl, pH 8.5, 15% ethanol. The 
DNA was precipitated with 0.7 volumes isopropanol and pelleted by 
centrifugation. The pellet was washed with 70% ethanol and the DNA 
resuspended in 70 - 200 ȝl of TE buffer.  
2.2.4.2 Restriction enzyme digestion  
Restriction endonuclease digests were routinely conducted in 20 ȝl reactions 
containing 0.2 -1 ȝg DNA in the appropriate buffer with 1 unit of restriction 
enzyme. Digests were incubated at the required temperature (as recommended 
by the supplier), for 2 hours or more.  
2.2.4.3 Cloning sequences into plasmid vectors  
Appropriately digested, and purified DNA fragments, were ligated using T4 
DNA ligase according to the manufacturers recommendations. Vector DNA 
was dephosphorylated using Antarctic phosphatase (New England Biolabs) in 
accordance with the manufacturers recommendations. Fragment 
concentrations were quantified using a Beckman Coulter DU 530 
Spectrophotometer, such that the ligation reaction contained a three-fold molar 
excess of insert DNA ends to vector ends. Reactions were completed in a final 
volume of 10 ȝl for 15 min at room temperature. For improved efficiency, both 
cohesive-end and blunt-end ligation reactions were performed overnight at 4°C. 
Ligation reactions were transformed into competent DH5Į, and transformants 
obtained under the relevant selection.  
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2.2.4.4 PCR amplification of DNA  
Amplification of DNA followed an adapted procedure previously described 
(Mullis and Faloona, 1987; Saiki et al., 1988). Pairs of 5 and 3 primers, the 
required DNA template, dNTPs and Taq, Dynazyme or Phusion polymerase 
(New England Biolabs) were used with the appropriate buffers provided. PCR 
products were analysed by gel electrophoresis and purified by isolating the 
product from an agarose gel and purifying using the Qiagen Gel Extraction kit.  
2.2.4.5 Labelled DNA substrates  
End labelling  
Oligonucleotides were provided without a 5 terminal phosphate group, and 
were labelled by attaching a [32P] phosphate to the 5 terminus. The reaction 
mixture consisted of 100-500 ng DNA, 1 ȝl T4 Kinase, 1-2 ȝl [Ȗ32P]-ATP and 
a final concentration of 1× forward reaction buffer (70 mM Tris·HCl, pH 7.6, 
10 mM MgCl2, 100 mM KCl, 1 mM mercaptoethanol) in a total volume of 20 
ȝl. The reaction was incubated for 1 hour at 37 °C, and halted by incubating at 
65 °C for 15 minutes. The unincorporated, labelled ATP was removed by using 
Biospin P6 spin columns (Biorad).  
Annealing  
Oligonucleotides were annealed in 20 ȝl reactions, in a screw capped 
eppendorf, containing 0.2 ȝM of each oligo and 1× SSC. The mixture was 
placed in a hot block at 100 °C for 5 min, after which it was switched off and 
allowed to cool to room temperature. Salt was removed from the reaction using 
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a BIO-RAD P6 chromatography column, with buffer exchanged for distilled 
water. Oligonucleotides obtained from MWG-Biotech AG were 
phosphorylated after annealing in a 50 ȝl reaction containing 10 units T4 
polynucleotide kinase (PNK), 1× T4 ligase buffer incubated at 37 °C for 1 hour. 
Reactions were heat inactivated at 65 °C for 20 min. Oligonucleotides were 
purified from the reaction using a QIAquick nucleotide removal kit (QIAGEN), 
in accordance with manufacturers specifications, and eluted into 30 ȝl EB (10 
mM Tris·HCl pH 8.5).  
2.2.4.6 Gel electrophoresis  
Agarose gels  
DNA was typically resolved on a 1% (w/v) TBE agarose gel. Before loading, 
DNA was mixed with approximately 0.2 volumes Ficoll gel loading buffer (or 
0.2 volumes of 80% glycerol for quantification). 0.2 ȝg/ml ethidium bromide 
was added to gels to allow visualisation (or gels were stained in TBE buffer 
added with 2.5 SYBR Green (Invitrogen) for quantification) of DNA 
fragments under UV light using a BIO-RAD Gel Doc EQ and Quantity One 1-
D Analysis Software. Gels were run as standard at 90 V for approximately 1 
hour. DNA fragments were sized using 0.25 ȝg 1 kb ladder (New England 
Biolabs). 
Native polyacrylamide gel analysis  
Radiolabelled DNA substrates were purified and analysed by native gel 
electrophoresis. Acrylamide gels contained polyacrylamide/bisacrylamide 
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(29:1) and were polymerised with 0.1% ammonium persulphate and 0.05% 
TEMED. Gels were subjected to electrophoresis in a Biorad Protean II 
apparatus in running buffer identical to the gel buffer. Gels were dried by 
placing onto Whatman 3MM filter paper and dried on a vacuum slab drier. The 
dried gels were exposed to X-ray film or a storage phosphor screen (Molecular 
Dynamics).  
Sequencing gels 
Single strand DNA oligos were purified on sequencing gels before application 
in in vitro DNA binding assays. Sequencing gels contained 12% 
polyacrylamide/bisacrylamide (29:1), 1× TBE and 46% (w/v) urea, and were 
polymerised with 0.1 ammonium persulphate and 0.05% TEMED. 
Electrophoresis performed at 2000 V for 3 hours. Gels were dried by placing 
onto Whatman 3MM filter paper and dried on a vacuum slab drier. Bands 
containing the appropriate DNA were visualised by UV shadowing and 
extracted of DNA by soaking the sliced gel containing the DNA with Elution 
Buffer (Qiagen). Purified DNA samples were quantified by absorbance at A260. 
2.2.4.7 Extraction of DNA from agarose gel  
DNA products were extracted from gel segments using a QIAquick Gel 
Purification kit (in accordance with the manufacturers specifications). DNA 
was eluted from the spin column and resuspended in 20 ȝl TE buffer, EB 
buffer or water.  
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2.2.5 Preparation and analysis of proteins  
2.2.5.1 Protein overexpression  
Standard procedures (apply for all proteins except for Seleno-methionine 
derivatives) 
Overexpression of cloned genes in E. coli was tested on a small scale before 
large-scale purifications. Samples from fresh 5 ml overnight cultures, made 
from freshly transformed colonies, were used to inoculate 8 ml of Mu broth; 
the appropriate selection was maintained at all stages. The secondary cultures 
were grown to an A650 of 0.4 - 0.5 at 37 °C, and if selection was maintained by 
the ȕ-lactamase gene, carbenicillin was added to a final concentration of 0.25 
mg/ml. Chloramphenicol or kanamycin was added to maintain plasmid pLysS 
or pT7Pol26, respectively. A sample of the culture was removed as a zero 
timepoint, the remainder split into two, and inducer added to half. Unless 
otherwise stated in the text, induction was with 1 mM IPTG for the T7 
promoter driven systems. Other promoter systems used are described in the text. 
Overexpression was typically for 3 hours. Total cell protein was analysed by 
SDS PAGE, using 1 ml of culture spun down into 150 ml 1× Disruption buffer. 
Overexpression on a preparative scale was performed using 1 L baffle flasks 
containing 400 ml Mu broth, inoculated with 3 - 5 ml of a fresh culture. Details 
are otherwise as for small scale overexpression.  
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Overexpression for Seleno-methionine (SeMet) derivatives 
This protocol is based on (Doublie, 1997), and adjusted according to procedure 
from the laboratory of Jonas Emsley (Nottingham). Samples from fresh 5 ml 
overnight cultures, made from freshly transformed colonies, were used to 
inoculate 1 L baffle flasks containing 300 ml 56/2 and 3 ml 20% glucose; the 
appropriate selection was maintained at all stages. The secondary cultures were 
grown to an A600 of 0.3 at 37 °C, and metabolic inhibition was achieved by 
adding L-Lysine, L-Phenyalanine and L-Threonine at 100 mg/l, and L-
Isoleucline, L-Leucine and L-valine at 50 mg/l, and finally L-SeMet at 50 mg/l; 
all solutions were syringe filtered before addition. After a 15 minutes period of 
incubation, a sample of the culture was removed as a zero timepoint, the 
remainder was induced with 1 mM IPTG for the T7 promoter driven systems. 
Overexpression was typically for 15 hours. Total cell protein was analysed by 
SDS PAGE, as for the standard procedures. 
2.2.5.2 Protein purification  
E. coli cultures containing overexpressed protein were harvested by 
centrifugation and the cell pellet resuspended in Buffer A (5-10 ml per g cells). 
Cell lysis was completed by sonication using a Soniprep 150 (MSE): 20 ml 
volumes were subjected to 6×30 second pulses at 8 microns on ice. Soluble 
protein and cell debris were separated by centrifugation (30,000 RCF, 20 
minutes, 4 °C), and samples of each analysed by SDS PAGE. The soluble 
fraction was filtered through a 0.45 ȝm filter (Millipore) and subjected to 
further purification steps using various columns.  
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2.2.5.3 Column chromatography  
Column chromatography was performed on FPLC (GE Healthcare) following 
standard procedures. All columns used in this study were purchased from GE 
Healthcare. Column chromatography buffers (section 2.1.1.2) were prepared 
and filtered under vacuum. All purification steps were performed at 4 °C or on 
ice, from the point at which cells were lysed. UV absorbance at 280 nm was 
used to detect protein peaks during column chromatography. SDS PAGE and 
the Bradford assay were used for subsequent protein analysis. Protein samples 
were filtered through 0.45 ȝm filters before loading onto the column to prevent 
blockages.  
2.2.5.4 SDS-PAGE  
Proteins were separated by one-dimensional electrophoresis using the Novex 
(Invitrogen) system throughout. The protein gels were separated into resolving, 
and stacking components. The resolving gel contained 12.5% acrylamide/ bis-
acrylamide 29:1, 0.375 M Tris·HCl pH 8.8, and 0.1% (w/v) SDS. The stacking 
gel contained 5% acrylamide/ bis-acrylamide 29:1, 0.125 M Tris·HCl pH 6.8, 
and 0.1% SDS. Both portions of the gel were polymerised using 0.08% 
ammonium persulphate and 0.08% tetramethylethylene diamine (TEMED). 
Protein samples were prepared by mixing the sample and 1/2 volume of 3× 
SDS loading buffer, and heating to 95 °C for 5 minutes. Protein samples were 
loaded onto the gel, and run at 180 V/40 mA for 80 minutes in SDS PAGE 
running buffer. Gels were stained using Thermo Scientific GelCode Blue Safe 
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Protein Stain; excess stain was removed by soaking in water from 2 hours to 
overnight with gentle agitation.  
2.2.5.5 Measurement of protein concentration  
Protein concentrations were estimated using a Biorad Protein Assay. The A595 
of a series of 1-24 ȝg/ml aliquots of BSA protein standard were determined, 
and compared to the A595 of the sample protein.  
2.2.6 Crystallography 
2.2.6.1 Protein preparation 
The protein sample for crystallography was purified by standard procedures, 
and was finally exchanged in buffer B by gel-filtration column. It was kept at 4 
ºC or on ice before the subsequent crystallisation, or kept at -80 ºC for long 
term storage. 
2.2.6.2 DNA preparation 
Oligonucleotides were bought from MWG. For ssDNA co-crystallisation, the 
oligonucleotides were mixed with the proteins directly. For dsDNA co-
crystallisation, the oligonucleotides were annealed in 200 ȝl reactions, in a 
screw capped eppendorf, containing 0.5 mM of each oligo and 1× SSC. The 
mixture was placed in a PCR reactor starting at 95 ºC for 60 seconds, then 
entering a slope with decreasing temperature at 0.5 ºC per 12 seconds until it 
was 70 ºC. A less steep slope followed at 0.5 ºC per 60 seconds until it was 40 
ºC, then the temperature was decreased at 0.5 ºC per 12 seconds again until it 
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was 4 ºC, at which point the reaction was held. The sample was run on a 15% 
polyacrylamide TBE gel with an un-annealed single strand oligonucleotide as a 
reference at 100 V for 2 hours. The gel was wrapped in Saran film and covered 
by a 2-ply silver foil to protect the majority amount of the annealed sample 
from the subsequent UV shadowing for locating the band. The un-irradiated 
portion of the band was excised and soaked with EB buffer at 4 ºC for 
overnight. The eluted DNA was concentrated to 100-200 ȝl by centrifugation 
in a pre-washed Vivaspin 6 5000 MWCO column at 6000 RCF, 8 ºC, or by 
using a Vivapore 7500 MWCO at 4 ºC. The DNA concentration was 
determined by the absorbance at A260. 
2.2.6.3 Crystallisation 
Protein and DNA samples were mixed in ice cold buffer B and incubated on 
ice for 5 minutes, and were centrifuged at 13,000 rpm on a benchtop at 4 ºC for 
10 minutes. The supernatant was transferred to a new tube, if there was pellet 
on the bottom of the tube. The samples were either crystallised manually, or by 
the Matrix Hydra high throughput crystallisation robot. 
High throughput crystallisation 
100 ȝl from a mother liquids set chosen for crystallisation screen was injected 
into each reservoir of a 96-cell CrystalQuick plate (Greiner Bio-one). 0.6 ȝl of 
each mother liquid was then moved to the three sample wells elevated in each 
cell to mix with 0.6 ȝl crystallisation samples. The plate was then sealed 
carefully by Crystal Clear Sealing Tape (Hampton Research) to completely 
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separate each cells. The plates were typically incubated at 10 ºC for 2-7 days 
and the results were rated by the visual inspection. 
Sitting drop vapour diffusion in large scale 
Mother liquids were added to a 24-cell Cryschem plate (Hampton Research). 
500 ȝl of each mother liquid was added to appropriate reservoirs. 2 to 4 ȝl of 
each mother liquid was moved to the sample well by a Gilson P10 pipette. 
Same amount of crystallisation sample was added to mix with the mother 
liquid in each sample well. The plate was sealed with Crystal Clear Sealing 
Tape (Hampton Research) to separate each cells. The plates were incubated at 
10 ºC, 13 ºC or 4 ºC. 
Crystal dissolving 
The liquid soaking the selected crystals was removed by a Gilson P10 pipette. 
The mother liquid from the reservoir in the same cell was used to wash the 
crystal for 4-5 times, and finally the crystal was dissolved with 5 ȝl of water. 
The protein was digested by Proteinase K at room temperature for 20-30 
minutes. 
2.2.7 Plasmid constructions and site-directed mutagenesis 
The plasmids carrying mutant rdgC genes (Table 2-4) were generally 
constructed in two different ways. The pYJ plasmids were constructed with 
site-directed mutagenic PCR. Forward and backward primers were designed to 
overlap each other to introduce the base substitutions as required. The PCR 
reactions were catalysed by Phusion. The conditions of the PCR reactions were 
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designed based on QuikChange® Site-Directed Mutagenesis Kit (Stratagene). 
The PCR products were digested by Dpn I restriction enzyme to remove 
parental supercoiled DNA, and were transformed into DH5Į. After an 
overnight growth at 37 ºC, transformants were selected and the mutant 
plasmids were extracted and sequenced for confirmation of the base 
substitutions. 
The pGB plasmids were PCR constructed with the help from Dr G. S. Briggs, 
by using two adjacent primers. Since the Phusion enzyme used in the PCR 
reactions does not add phosphate at product ends, the PCR products were 
phosphorylated before religation. In this case, a unique diagnostic restriction 
site was always introduced by the primers to ensure that the correct plasmids 
were collected. For chunk deletions (rdgC¨F and rdgC¨F·R118C), two identical 
restriction sites were introduced by primers to both ends of the desired deletion 
region. The PCR products were digested by the appropriate enzyme and 
religated afterwards. 
2.2.8 In vitro DNA binding assays  
2.2.8.1 Linear DNA binding assays  
Labelled DNA and protein were mixed on ice in GBB, and binding was 
allowed to proceed on ice for 15 minutes. Samples were run on a 4% 
polyacrylamide gel made with the appropriate LIS buffer and polymerised with 
0.1% AMPS and 0.05% TEMED. Electrophoresis was completed at 160 V for 
90 minutes, and the gels were dried on filter paper before being analysed by 
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phosphorimagery or autoradiography. The data were collected by using the 
Storm, and analysed by using ImageJ (Abramoff et al., 2004). 
2.2.8.2 Plasmid DNA binding assays 
Plasmid DNA and protein were mixed and incubated as in 2.2.8.1. Samples 
were run on 1% agarose gel. Electrophoresis was completed at 80 V for 90 
minutes. Gels were stained by SYBR Green and visualised under UV light. 
2.2.9 Chromosome Recombineering 
As illustrated in Figure 2-1, plasmids carrying mutant rdgC genes of interests 
(Table 2-4) were digested at the HindIII site immediately downstream of rdgC, 
where a cat HindIII-HindIII fragment encoding chloramphenicol resistance 
was ligated. The region of rdgC-cat was amplified by PCR. PCR primers were 
designed to contain ~25 bases homology to either ends of the target genes 
(usually including a resistance marker gene) on a plasmid, and ~40 bases 
homologous to chromosomal gene insertion points. The plasmid was usually 
linearised by an appropriate restriction enzyme before the PCR. PCR products 
were removed for template by Dpn I and were dialysed on nitrocellulose filter 
disc against 1 mM HEPES for 30 minutes. The PCR products were then 
transformed into ¨rdgC::dhfr or ¨rdgC2::dhfr strains harbouring the pKD46 
by electroporation (refer to 2.2.2.2; note that the transforming DNA were PCR 
products, rather than plasmids), and recombineered  to replace the 
chromosomal ¨rdgC::dhfr or ¨rdgC2::dhfr with the help of pKD46. pKD46 is 
a temperature sensitive plasmid that encodes the phage Ȝ Red recombinase and 
can be removed by growing the cells at 37 ºC for overnight (Datsenko and 
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Wanner, 2000). For the same reason, the electroporated cells were recovered at 
30 ºC for 2 hours, instead of 37 ºC for 1 hour in the common procedure (see 
2.2.2.2 for details). The recombineered sequences in the chromosome were 
confirmed by PCR mediated sequencing using primers Pro/rdgC-5 and 
rdgC/Cm-3. Chromosomal rdgC was deleted in the same way by introducing 
¨rdgC::dhfr or ¨rdgC2::dhfr, which was confirmed by PCR mediated 
sequencing using primers Tm/rdgC-5 and Tm/rdgC-3. rdgC from Neisseria 
meningitidis was also engineered to replace the native rdgC in E. coli with the 
same method. Its presence in the chromosome was confirmed by PCR 
mediated sequencing using primers RdgC/Nm-5 and RdgC/Cm-3. 
 
Table 2.4 rdgC mutants 
Amino acid mutation 
Base 
changes 
PCR primers 
Plasmid 
construct 
Recombineered 
strain 
K211A AAAåGCA YJ21/YJ22 pYJ014 AM1839 
Q212A TCGåGCA YJ29/YJ30 pYJ017 AM2029 
E218R GAGåCGC YJ13/YJ14 pYJ013 AM1840 
H222A CACåGCC YJ17/YJ18 pYJ006 
pYJ003 
AM1836 
K227A AAAåGCA YJ19/YJ20 pYJ007 AM1837 
R118C CGTåGTG GB-P37/34 pGB047 
pGB045 
AM1833 
R118A CGTåGCG GB-P41/42 pGB050 
pGB049 
AM1838 
F120T TTCåACG GB-P47/48 pGB054 
pGB053 
AM1905 
F120S TTCåAGC GB-P45/46 pGB052 
pGB051 
AM1917 
R118C·F120T 
GCGåGTG 
TTCåACG GB-P77/78* pGB065 YJ025 
P76G,L116T,¨(77-115) CCGåGGT 
CTGåACC GB-P29/30 pGB043 AM1834 
P76G,L116T,¨(77-
115),R118C 
CCGåGGT 
CTGåACC 
CGTåGCG 
GB-P37/35 
pGB048 
pGB046 
AM1835 
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R97S,K98Q,K100Q,K101E 
CGTåAGT 
AAGåCAG 
AAGåCAG 
AAAåGAA 
GB-P51/52 
pGB056 
pGB055 
AM1950 
     
* The primers introduced base substitutions for F120T; R118C was borrowed from 
pGB045 as a NdeI/AatII fragment. 
 
2.2.10 Synthetic lethality assays  
The assay used an unstable lac+ plasmid, pRC7, carrying a wild type gene of 
interest to cover a deletion allele in the chromosome of a lac- strain. If any 
further mutation is lethal with the covered mutation, plasmid-free segregants 
fail to grow and only plasmid carrying cells forming blue colonies are seen on 
an indicator plate containing IPTG and X-gal. IPTG induces the expression of 
the lac operon on the pRC7 plasmid, and the expression product digests X-gal 
on the plate, transforming the cells having the plasmid to blue. If the further 
mutation is not lethal with the covered mutation, plasmid free segregants form 
healthy white (lac-) colonies.  
Stock cultures of strains carrying pAM374 (a pRC7 derivative, encoding PriA) 
were diluted 80-fold in LB broth and grown with no ampicillin selection to 
A650 0.4 before plating dilutions on LB or minimal agar supplemented with X-
gal and IPTG. Plates were photographed and scored after 48 hours (if LB) or 
72 hours (if minimal) of incubation. White colonies formed by plasmid-free 
cells could be subcultured on LB or minimal agar where appropriate. The 
method details can be found in (Mahdi et al., 2006).
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 Figure 2-1 General procedure of recombineering 
This is an example to use rdgCK211A from a plasmid to replace ¨rdgC::dhfr in the chromosome 
of a TB28 derivative. All the other mutant rdgC were recombineered in the chromosome 
following the same procedure. The green bars indicate homologous sequences. 
 
A. A HindIII-HindIII fragment of cat gene was ligated immediately downstream of
rdgCK211A in a plasmid (usually a pET22b derivative). 
B. The region of rdgCK211A-cat was PCR amplified with primers containing sequences
homologous to ¨rdgC::dhfr flanking sequences in the chromosome of a TB28
derivative. 
C. pKD46 encoding protein phage Ȝ Red recombinase mediated recombination that
would replace ¨rdgC::dhfr with rdgCK211A-cat. 
D. The recombinants were incubated at 37 ºC for overnight. The temperature sensitive
plasmid pKD46 was lost. 
A B
CD 
TB28 
rdgCK211A-cat 
¨rdgC::dhfr 
TB28 ¨rdgC 
pKD46 
37 ºC 
pKD46 
rdgCK211A 
HindIII 
cat 
pYJ014 Plasmid 
PCR 
rdgC 
K211A 
cat 
Recombineering 
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Chapter 3 
Structural analysis of RdgC 
3.1 Background 
RdgCs association with DNA recombinational repair is thought to be achieved 
by binding to DNA, however, its DNA binding does not show any sequence or 
structural preference. This poses the question of how RdgC achieves its effect 
on the recombination reaction. 
Attempting to answer this question, I overexpressed, purified and crystallised 
the protein. Its seleno-methionyl derivative was also crystallised for phase 
determination (selenium replacing the sulphur in all methionine residues of the 
protein, therefore giving an opportunity to determining the phase). The 
structure of RdgC was finally determined by X-ray crystallography. 
3.2 Crystallisation of RdgC 
3.2.1 Cloning and Overexpression of native RdgC 
The rdgCwt gene had previously been cloned into pT7-7, generating pGS853, 
which can be used to overexpress RdgC (Moore, 2002). For a tight control of 
overexpression, the rdgC coding sequence was subcloned as an NdeI-HindIII 
fragment in pET22b, forming pYJ001. pYJ001 was transformed either into 
BL21 (DE3) pLysS cells or STL2669 pT7Pol26 cells. Overexpression was 
carried out as described (see 2.2.5.1). The protein was visible without 
purification after overexpression (Figure 3-1). 
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3.2.2 Purification of native RdgC 
The cells expressing RdgC were lysed by sonication on ice. RdgC in the 
supernatant was precipitated by performing a two-step ammonium sulphate 
precipitation. The supernatant from the 0  40% ammonium sulphate cut was 
collected for a second ammonium sulphate cut from 40  65%. The precipitate 
containing RdgC was resuspended in buffer A containing 0.3 M NaCl and 
cleaned by a 0.45 micron filter before it entered column chromatography stages. 
The first column to purify RdgC was a heparin column (HiTrapTM Heparin HP 
5 ml (GE Healthcare)) and it removed most impurity in the solution (Figure 3-
2). Fractions containing RdgC were applied to a Q sepharose (HiTrapTM Q 
Sepharose HP 5 ml (GE Healthcare)). After this stage the solution was applied 
to the heparin column for concentration due to the 5 ml loading limit of the 
following gel filtration column (Sephacryl 16/60 S200HR). After purification 
by the gel filtration column, the protein was concentrated and quantified on the 
assumption that the protein is a dimer (see 1.5), with a total mass of 68 kDa. 
Note that RdgC for crystallisation was not dialysed against 50% glycerol as it 
might hamper crystal growth. 
3.2.3 Overexpression of seleno-methionyl RdgC 
The protein was overexpressed from E. coli BL21 (DE3) carrying pLysS and 
pYJ001 (as native RdgC) using feedback inhibition of methionine biosynthesis, 
as described (Doublie, 1997). The detailed procedure can be found in 2.2.5.1. 
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Figure 3-1 12.5% SDS-PAGE gel showing overexpression of Escherichia coli wild type RdgC. 
Lane 1, molecular weight markers; Lane 2, UI: insoluble lysate from uninduced cells; Lane 3, 
II: insoluble lysate from induced cells; Lane 4, US: soluble lysate from uninduced cells; Lane 5, 
IS: soluble lysate from induced cells. 
 
 
 
Figure 3-2 12.5% SDS-PAGE gel showing ammonium precipitation and column stages of 
purification of Escherichia coli wild type RdgC  
Lane 1, molecular weight markers; Lane 2, whole cell lysate from induced cells; Lane 3, 
insoluble whole cell lysate; Lane 4, soluble whole cell lysate; Lane 5, insoluble fraction of 0-
40% (NH4)2SO4  cut; Lane 6, soluble fraction of 0-40% (NH4)2SO4 cut; Lane 7 insoluble 
fraction of 40-65% (NH4)2SO4 cut; Lane 8 soluble fraction of 40-65% (NH4)2SO4  cut; Lane 9-
12, collected fractions from a series of columns as indicated above the lanes. Note that 
Heparinp indicates the Heparin column was used for purification, whereas Heparinq was used 
for concentrating. GF stands for Gel-filtration; Lane 13, Concentrated RdgC. 
 
M
ar
ke
rs
 
U
I 
II
 
U
S
 
IS
 
35 kDa 
25 kDa 
18.4 kDa 
45 kDa 
M
ar
ke
rs
 
W
L
 
IW
L
 
S
W
L
 
I.
0-
40
%
 
S
.0
-4
0%
 
I.
40
-6
5%
 
S
.4
0-
65
%
 
H
ep
ar
in
ķ
 
Q
 
H
ep
ar
in
ĸ
 
G
F
 
C
.R
dg
C
 
50 kDa 
40 kDa 
30 kDa 
70 kDa 
25 kDa 
20 kDa 
15 kDa 
RdgC 
1 2 3 4 5 
1 2 3 4 5 6 7 8 9 10 11 12 13 
RdgC 
54 
 
 
 
 
 
 
 
Figure 3-3 12.5% SDS-PAGE gel showing ammonium precipitation and column 
stages of purification of Se-Met RdgC  
Lane 1 and 14, molecular weight markers; Lane 2, whole cell lysate from induced 
cells; Lane 3, insoluble whole cell lysate; Lane 4, soluble whole cell lysate; Lane 5, 
insoluble fraction of 0-40% (NH4)2SO4  cut; Lane 6, soluble fraction of 0-40% 
(NH4)2SO4  cut; Lane 7 insoluble fraction of 40-65% (NH4)2SO4  cut; Lane 8 soluble 
fraction of 40-65% (NH4)2SO4  cut; Lane 9-13, 15-20 collected fractions from a series 
of columns as indicated above the lanes. Note that Heparinķ indicates the Heparin 
column was used for purification, whereas Heparinĸ was used for concentration. GF 
stands for Gel-filtration; Lane 21, Concentrated Se-Met RdgC. 
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3.2.4 Purification of seleno-methionyl RdgC 
The whole procedure was performed as for E. coli native RdgC (3.2.3) (Figure 
3-3). Incorporation of Se-Met was confirmed by the proteins molecular weight, 
obtained by mass spectrometry. 
3.2.3 Crystallisation trials 
3.2.3.1 High throughput crystallisation 
The three samples prepared for crystallisation screening were E. coli native 
RdgC alone, E. coli native RdgC with YJ1 (a 21 nt ssDNA) and E. coli native 
RdgC with YJ5 (a 15 nt ssDNA).  The concentrations in the crystallisation mix 
of protein and DNA were both 100 ȝM. When RdgC was crystallised alone, the 
portion for DNA was replaced by Elution Buffer (Qiagen). 
The Matrix Hydra high throughput crystallisation robot was applied to operate 
crystallisation on 96-cell crystallography plates. The three mother liquid suites 
selected for crystallisation screening were Classic Suite, MPDs Suite and PEGs 
Suite (Hampton research). Crystals were grown at 10 ºC by sitting drop vapour 
diffusion, with a 1:1 ratio of complex and reservoir solution in each drop. The 
results of the trials are shown in Table 3-1, Table 3-2 and Table 3-3, 
respectively. 
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Table3 ?1TheClassicsSuite
Motherliquid Crystalforms
Salt Buffer Precipitant RdgC RdgC:YJ1 RdgC:YJ5
Null
0.1MHEPES
sodiumsalt
pH7.5
2%(v/v)PEG
400,2.0M
Ammonium
sulfate
 Bigsize,cube
likecrystals 
0.2M
Ammonium
acetate
0.1Mtri ?
Sodium
citratepH
5.6
30%(w/v)
PEG4000 Needles  Needles
0.2M
Ammonium
sulphate
0.1MMES
pH6.5
20%(w/v)
PEG5000
MME
Needles  Needles
 
Table3 ?2TheMPDsSuite
Motherliquid Crystalforms
Salt Buffer Precipitant RdgC RdgC:YJ1 RdgC:YJ5
0.2Mdi ?
Ammonium
phosphate
Null 40%(v/v)
MPD
Bigsize,
cubelike
crystals
 Needles
 
Table3 ?3ThePEGsSuite
Motherliquid Crystalforms
Salt Buffer Precipitant RdgC RdgC:YJ1 RdgC:YJ5
0.2M
Magnesium
nitrate
Null 20%(w/v)
PEG3350
Needles
andplates
Needlesand
plates 
0.2M
Magnesium
sulfate
Null 20%(w/v)
PEG3350 Plates Plates 
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3.2.3.2 Sitting drop vapour diffusion in large scale 
Crystallisation in large scale was operated on 24-cell crystallography plates. E. 
coli native RdgC was crystallised with different lengths and structures of DNA 
substrates (see Table 3-4; the sequences of the composing oligonucleotides can 
be found in Table 2-3).  
Based on the results of high through-put crystallisation, the protein:DNA 
complexes (the DNA molecule was either ssDNA or blunt duplex) and the 
protein alone  were crystallised in CaCl2 or MgCl2 as salt, HEPES (pH 6.5-8.5) 
as buffer, and PEG (400, 1000, 2000, or 4000) as precipitant. Crystals were 
grown at 10 ºC, 13 ºC, or 4ºC.   
After many trials, the optimal conditions for crystallisation were identified as 
when RdgC co-crystallised with YJ7/8 at 10 ºC, from 200 mM CaCl2, 100 mM 
HEPES pH 7.0-7.5, and 15-20 % PEG 1000. Crystals under such conditions 
grew up to 400 × 200 × 200 ȝM (Figure 3-4 A). Crystallisation in the absence 
of DNA produced smaller and non-isomorphous crystals, and diffracted to only 
2.8 Å. 
Since the blunt dsDNA and ssDNA molecules applied in crystallisation could 
not be located in the structure (see below for details), I also made some unusual 
DNA substrates in the hope to trigger a distinctive interaction between RdgC 
and DNA, or that the conformation of the DNA molecules could help 
themselves arrange in the crystal in a unique manner. The expected structures 
of the unusual DNA substrates include duplexes with a bubble, or hairpin at 
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one or both ends, overhangs, and a duplex with a kink (Table 3-4). 
Unfortunately, the DNA still remained invisible in the crystal structure.  
Table3 ?4DNAsubstratesforcrystallography
Name Length Structure
YJ1 21nt


YJ3 18nt
YJ5 15nt
YJ7 19nt
YJ1/2 21bp

YJ3/4 18bp
YJ5/6 15bp
YJ7/8 19bp
YJ9/10 17bp
TMRC1/1R 19bp
YJ1/10 17bpwith4ntoverhangs

YJ1/6 15bpwith6ntoverhangs
YJ2/5 15bpwith6ntoverhangs
YJ2/9 17bpwith4ntoverhangs
TMRC1M1/1R 19bpwith1mismatch
bubble
TMRC1M3/1R 19bpwith3 mismatch
bubble
TMRC2 ?DUMB 18bpwith4nthairpins
atbothends TMRC3 ?DUMB
TMRC1M1/1 ?D1 18bpwithakink.

YJ11 18bpwitha4nthairpinat
oneend
YJ12 17bpwitha4nthairpinat
oneend
59 
 
 
In order to confirm the presence of DNA in the crystals, some washed and 
dissolved crystals were analysed by gel electrophoresis on a 15 % 
polyacrylamide TBE gel. As illustrated in Figure 3-4 B, DNA existence was 
confirmed both in the drop solvent and the crystals. Its lacking density for 
DNA in the Fo-Fc difference map may be related to the mode of RdgC:DNA 
binding. 
 
 
 
 
 
 
 
 
 
 
Figure 3-4 RdgC crystal and EMSA assay proving the presence of DNA in the crystal 
A. E. coli native RdgC and YJ 7/8 (19 bp dsDNA) crystallised to 400 x 200 x 200 ȝM 
B. Washed crystal of (Se-Met RdgC:YJ 7/8) was solved and run on a 15% polyacrylamide 
TBE gel. Lane 1, drop solvent; Lane 2, washed and solved crystal. 
A B
S
olvent 
C
rystal 
YJ7/8 
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3.3 X-ray diffraction 
Crystals for diffraction were harvested by Dr Geoffrey Briggs. Data for the Se-
Met derivative were collected on ID14-4 at the European Synchrotron 
Radiation Facility with a wavelength of 0.98 Å. Data processing was 
performed by Paul McEwan (Nottingham). The structure presented in section 
3.4 below is for the Se-Met RdgC co-crystallised with YJ7/8 (19 bp blunt 
dsDNA), which was solved to 2.4 Å. 
The packing of RdgC molecules in the crystal lattice allows holes to form long 
and continuous pores (Figure 3-5 A). However, no additional density was 
observed in the Fo-Fc difference map that could be used to locate the DNA, 
despite the evidence of its presence in the crystal (3.2.3.2). 
 
3.4 Structure of RdgC 
The data generated were used to solve the structure of RdgC. This part of the 
project was conducted by Dr Geoffrey Briggs in collaboration with Paul 
McEwan, although I was closely associated with the structure determination 
throughout. 
In agreement with previous studies (Moore et al., 2003), RdgC crystallises as a 
dimer, with a head to head, tail to tail organisation (Figure 3-5 B and C). The 
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dimer forms a ring structure, with a 30 Å diameter central hole (C alpha to C 
alpha). 
The RdgC protein is a unique fold, as revealed by the Dali server (Holm and 
Sander, 1993). The overall protein fold adopts a toroidal structure mimicking a 
horseshoe, with two gates closing the open end (Figure 3-5 B). The inner face 
consists of 8 anti-parallel ȕ strands, with one of the dimer interfaces (horseshoe 
interface) falling between the 4th and 5th strands. They are covered by 2 anti-
parallel helices on the outer surface. The horseshoe interface is held together 
by hydrogen bonds between the ȕ strands and between a triad of highly 
conserved residues at the ends of the helices: Q212 and E218 from one 
monomer and K227 from the other. The conserved histidine, H222, completes 
the dimer interface (Figure 3-6 and 3-7 A). 
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Figure 3-5 Overall structure of RdgC 
A. Crystal packing of RdgC rings to from long pores through the lattice. 
B. Ribbon diagram showing the ring structure of the RdgC dimer and identifying the
horseshoe and gate regions. The two chains are differentiated by shades of red and green.
Note that the N-termini are buried in the molecule, and the C-termini are exposed outside.
The open circle marks the location of one of the finger domains. 
C. Horizontally rotated ribbon diagram showing the bottom and the finger domains. 
A 
Fingers 
Fingers 
Horseshoe 
Gate Gate 
B C
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The second dimer interface lies where the two regions of extended ȕ strand 
forming the gates overlap. Unlike the horseshoe dimer interface, the gate 
interface is primarily maintained by hydrophobic interaction, where a 
conserved phenylalanine, F120, on one chain sits in a pocket formed by highly 
conserved residues on the other chain: I74, L75, P76, V79, L115, L116, R118, 
A119 and F120, and vice versa (Figure 3-6 and 3-7 C). The hydrogen bond 
formed between the guanidinium and carbonyl groups of the R118 residues 
provides additional stabilisation (Figure 3-7 D). 
 
MLWFKNLMVYRLSREISLRAEEMEKQLASMAFTPCGSQDMAKMGWVPPMGSHS*DALTHVANGQIVICARKEEK
ILPSPVIKQALEAKIAKLEAEQARKLKKTEKDSLKDEVLHSLLPRAFSRFSQTMMWIDTVNGLIMVDCASAKKA
EDTLALLRKSLGSLPVVPLSMENPIELTLTEWVRSGSAAQGFQLLDEAELKSLLEDGGVIRAKKQDLTSEEITN
HIEAG*KVVTKLALDWQQRIQFVMCDDGSLKRLKFCDELRDQNEDIDREDFAQRFDADFILMTGELAALIQNLI
EGLGGEAQR 
*MWFKNLMTYRLTKPLDWDLAQLQTQLEDCQFHPCGTQDQSKFGWSAPLR*GS*DLLYFSVGKQILLIAKKEEK
ILPANVVKRELDDRIESLEQKENRKLKKVEKQTLKDDVVMNLLPRAFSKNQHTALWIDTENNLIHIDAASSKRA
EDALALLRKSLGSLPVVPLAFANEPSTILTNWILQDNLPHWLLALEEAELRGSQEDS*VIRCKKQPLENEEILA
LLQDGKKVVSKLALEWEDTLTFVFNEDCTIKRLKFADTVREKNDDILKEDFAQRFDADFVLMTGILAKLTENLL
DEFGGEKARL 
*MWFRNLLVYRLTQDLQLDADSLEKALGEKSARPCASQELTTYGFTAPFGKGPDAPLVHVSQDFFLISARKEER
ILPGSVVRDALKEKVDEIEAQQMRKVYKKERDQLKDEIVQTLLPRAFIRRSSTFAAIAPSLGLILVDSASAKKA
EDLLSTLREALGSLPVRPLSVKVAPTATLTDWVKTQEAAGDFHVLDECELRDTHEDGGVVRCKRQDLTSEEIQL
HLTAG*KLVTQLSLAWSDKLSFVLDDKLAVKRLRFEDLLQEQAEKDGGEDALGQLDASFTLMMLTFAEFLPALF
EALGGEEIPQGV 
*MWFKQISFYPLNKEKLPEADVLADKLAEAEFTHCQGLDWFSEGFTAPVSFSP**ELVFPADFTLRVALKKEEK
VLPAGVIRDILEEKVAEIQNNEARNVGRKEKQELKEQITDDLLPRAFTRSSRTEAVFNTRHGYLLVNNAASAKA
ENILTKLREALGGLEASLPNTKQSPSSLMTGWLLQGHCEGGFELDSDCELKGTGDIVPVVKVSKQDLTADEVVQ
HVKNG*KTVTQLGLVWREQIAFILTQDFTLKRIQYLDVLQEEAES*NGDDAAGLAFASQILMAESVSIMLEELV
SYLGGWQD 
¨ ¨ 
Figure 3-6 Alignment of RdgC 
Eco=E. coli; Hin=Haemophilus influenzae; Pae=Pseudomonas aeruginosa; Nme=Neisseria 
meningitidis. Highly conserved residues have green shading. Residues with triangles participated 
in mutagenesis studies. Residues shaded in light blue correspond to the numbering on their top. 
The grey-blue bar marks the residues underneath composing the finger domain, from S77  L115. 
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Two anti-parallel Į helices extended from the gate interface project 
perpendicular to the ring on either side, dubbed as finger domains. They 
range from S77 to L115 and contain a high proportion of conserved lysines, 
rendering a highly electropositive upper surface. The turn between the two 
helices is also electro-positively charged, attributing to an arginine (R97) and 
three lysines (K98, 100, 101) (Figure 3-7 B). The two finger domains do not 
have identical conformations in the crystal structure, a possible consequence of 
non-specific crystallographic contacts. It may also reflect their high B factors, 
and it is possible that some flexibility is necessary for protein function. 
The net charge of RdgC is highly negative at physiological pH, since a 
monomer has 27 glutamate, 20 aspartate, 23 lysine, 16 arginine and 4 histidine 
residues. Therefore the net charge of a dimer would be -8 if all histidines are 
positively charged. However, the charge distribution is non-uniform, with most 
negatively charged residues lying on the outer surface and most positively 
charged residues sitting around the wall of the centre hole (Figure 3-8 A). 
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R97
K98
K100
K101
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C D
Figure 3-7 Conserved residues at the dimer interfaces and finger domains (Briggs et al., 2007) 
A. A triad of conserved residues forming two hydrogen bond networks at the horseshoe
interface. 
B. An electrostatic surface representation showing the four basic residues at the tip of the
finger domain. 
C. A hydrophobic surface representation showing the pocket inserted with F120 at the gate
interface. 
D. R118 forming hydrogen bonds across the gate interface. 
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3.5 Discussion 
X-ray crystallography revealed that the RdgC dimer adopts a novel structure. 
Despite the evidence supporting the presence of DNA in the crystals, it could 
not be located in the structure of the DNA binding protein. This can be 
explained by its non-specific DNA binding as suggested by previous research 
(Moore et al., 2003).  
However, several lines of data suggest RdgC binds DNA by encircling it in the 
central hole of the dimer. 
1) The diameter of the central hole is 30 Å, which is readily able to 
accommodate a dsDNA (25 Å diameter in width). 
2) The central hole of the dimer is positively charged, which can directly 
interact with the negatively charged DNA backbone (Figure 3-8 A, B). 
This also explains limited preference on DNA structure and sequence. 
3) The proposed DNA binding channel is 40 Å from the front to the back 
of the ring and 55 Å from fingertip to fingertip. This area can interact 
with approximately 18 bp of DNA, in agreement of the size (15-20 bp) 
required to make a stable complex in vitro (Moore et al., 2003) (Figure 
3-8 C, D). 
4) The crystal packing of RdgC leaves only the central hole for 
accommodating the DNA (Figure 3-5 A). 
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Although a DNA duplex could fit in the central hole as modelled in Figure 3-8 
B, C and D, it was not directly obvious how RdgC might load on DNA. The 
following chapters describe my attempts to unravel the mechanism of DNA 
loading. 
 
DC 
BA 
Figure 3-8 Electrostatic surface representations of RdgC and modelling of DNA binding 
(Briggs et al., 2007) 
A. The ring of the RdgC dimer has an electropositive inner surface (blue) and an
electronegative outer surface (red). 
B. C. and D.  Three orientations of RdgC with duplex DNA modelled in the positive central 
hole. 
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Chapter 4 
The horseshoe interface 
4.1 Background 
The ring structure of RdgC suggests a simple mode of DNA binding  the ring 
encircles duplex DNA, thus limiting its exposure to RecA activity. This may 
explain how RdgC prevents illegitimate DNA recombination mediated by 
RecA. The active RecA:ssDNA filament searches homologous duplex and 
promotes strand exchanges between the two DNA molecules. The RdgC ring 
might cover the target dsDNA to prevent the recombination, or even halt it by 
robbing the dsDNA from the RecA:ssDNA filament. 
The question to this point is how RdgC loads onto DNA.  
a) Does it act only at DNA ends, in which case the closed ring might 
simply slide onto the DNA? However, this is not likely the case if 
RdgC blocks RecA loading at DNA gaps. Or 
b) Does the ring open to allow loading at any point on DNA? 
Preliminary studies using Atomic Force Microscopy suggest a possible 
preference for DNA ends (Tessmer et al., 2005). However, other data suggest 
RdgC could also bind circular plasmid DNA (Tessmer et al., 2005), which 
appears only achievable by opening the ring. 
I examined this aspect of RdgC in more details with mutagenesis assays. This 
chapter will focus on the studies concerning the horseshoe interface of the ring. 
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4.2 In vitro DNA binding assays 
4.2.1 Mutant design 
The horseshoe interface is held together by hydrogen bonds between the ȕ 
strands, and two sets of salt bridges formed in a triad of highly conserved 
residues at the ends of the helices: Q212 and E218 from one monomer and 
K227 from the other. H222 may also be involved. Since any change in the ȕ 
strands might disrupt the whole structure of the RdgC dimer, I only generated 
mutants for Q212 (pYJ017:RdgCQ212A), E218 (pYJ013:RdgCE218R), K227 
(pYJ007:RdgCK227A) and H222 (pYJ006:RdgCH222A). Another residue, K211, 
appears to be able to interact with the backbone of bound DNA duplex, thus 
the construction of RdgCK211A (pYJ014). 
  
 
 
K211 
Q212 
E218 
K227 
H222 
Figure 4-1 Ribbon diagram illustrating the horseshoe interface of RdgC dimer and the residues 
investigated in mutant studies. 
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4.2.2 Cloning, overexpression and purification 
4.2.2.1 Cloning 
Primers were designed to introduce base substitutions, on a plasmid with E. 
coli native rdgC gene fragment cloned between an NdeI site and a HindIII site. 
Normally the template plasmid was pYJ001, a pET22b derivative. After 
mutagenic PCR on pYJ001, the product was digested with Dpn I restriction 
enzyme to remove methylated parental DNA template. The treated sample was 
transformed into competent DH5Į cells. After proliferation of the cells, the 
plasmids of interest were purified, sequence checked and stored at -20 ºC. 
4.2.2.2 Overexpression 
In order to avoid chromosomally encoded wild type RdgC, the chromosomal 
rdgC gene was deleted in strain MG1655 to form N4586. ¨xonA300 was 
introduced to N4586 to form YJ012. The cells were then transformed with 
plasmid pT7pol26 to form YJ015 as an overexpression strain for mutant RdgC 
proteins. Another overexpression strain served for the same purpose stemmed 
from BL21 (DE3) pLysS, the chromosomal rdgC of which was deleted and 
replaced with dhfr to form YJ014. The plasmid having the mutant rdgC of 
interest was then transformed into an expression strain. The production of 
mutant RdgC proteins did not differ much in the two backgrounds (data not 
shown). 
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4.2.2.3 Purification 
Mutation of residues potentially affecting RdgCs DNA binding affinity might 
be expected to affect the affinity of the protein for a heparin column. Therefore 
the mutant proteins were purified on a linear gradient of 0.0-1.0 M NaCl in 
Buffer A (see Appendix 1). For the same reason, when concentrated by the 
Heparin column, the protein sample was washed in Buffer A without NaCl. 
Other than that purification was performed as for E. coli native RdgC. 
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Figure 4-2 12.5% SDS-Page gels showing purified mutant RdgC proteins with E. coli native 
RdgC 
Lane 1, Molecular weight markers; Lane 2, wild type RdgC; Lane 3-7, RdgC proteins with 
mutations as labelled on the top of each lane. 
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4.2.3 Single-stranded DNA binding assays 
In general, all tested mutants and the wild type RdgC were able to shift the 49 
nt ssDNA in electrophoretic mobility shift assays (EMSAs). The results show 
that RdgC formed two distinct complexes with the ssDNA oligo, RGL13 
(Figure 4-3 A, wild type). This is consistent with the RdgC structure, which 
could interact with approximately 18 bp of dsDNA. Although RdgC requires a 
slightly longer ssDNA for stable contact (Moore et al., 2003), the 49 nt RGL13 
is supposed to interact with two RdgC dimers simultaneously when RdgC is in 
excess (as illustrated on the right of WT in Figure 4-3 A).  
The horseshoe interface mutants exhibited different abilities to shift ssDNA. 
Among them, RdgCQ212A and RdgCH222A were able to shift the ssDNA to the 
same extent as the wild type. RdgCK211A bound with only slightly lower affinity, 
and as RdgCQ212A and RdgCH222A, it could shift the ssDNA as a sharp band. In 
contrast, RdgCE218R and RdgCK227A could not form a stable complex with 
RGL13 even in great protein excess. This resulted in massive complex 
dissociation during electrophoresis (Figure 4-2 A, bottom right, Lane 4). To be 
specific, wild type RdgC, RdgCQ212A and RdgCH222A started to shift 0.2 nM 
RGL13 at 1 nM (RdgC dimers:DNA§5:1); RdgCK211A started at 3 nM RdgC 
dimers:DNA§15:1); RdgCE218R and RdgCK227A barely started at 20 nM (RdgC 
dimers:DNA§100:1) (Figure 4-3 B). 
 
 
 
73 
 
Figure 4-3 RdgC binds ssDNA 
A. EMSA assays showing ssDNA binding of wild type RdgC and RdgC mutants with 
mutation at the horseshoe interface. DNA substrate was RGL13 (49 nt), at 0.2 nM. Protein 
concentrations: Lane 1, 0 nM; Lane 2, 5.92 nM; Lane 3, 23.68 nM; Lane 4, 1850 nM. 
RdgCH222A and RdgCK211A had similar shift pattern to the one of RdgCQ212A; RdgCK227A 
had similar shift pattern to the one of RdgCE218R. 
B. Binding isotherm for ssDNA binding (RGL13) of the RdgC proteins, assembled from at 
least 2 EMSAs. For the reactions, 0.2 nM RGL13 was used and the protein titrations were 
at 0, 0.37, 0.74, 1.48, 2.96, 5.92, 11.84, 23.68 and 1850 nM. The error bars stand for 
standard deviation at each value point. 
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4.2.4 Double-stranded DNA binding assays 
The assays were performed as for ssDNA binding, except that the DNA 
template was replaced by a linear and blunt-ended dsDNA of 49 bp 
(RGL13/17). 
E. coli RdgC can form stable complex with dsDNA longer than 15 bp (Moore 
et al., 2003), and therefore can saturate RGL13/17 (49 bp dsDNA) with 3 
dimers (Figure 4-4 A, WT). Not surprisingly, the mutants exhibited similar 
relative DNA affinities for RGL13/17 as for RGL13 (Figure 4-4 A), indicating 
that RdgC uses the same binding channel for dsDNA and ssDNA. In agreement 
with previous study (Moore et al., 2003), all of the proteins formed complexes 
more stable with RGL13/17 than with RGL13.  
To be specific, wild type RdgC, RdgCQ212A and RdgCH222A showed signs of 
shift at 0.3 nM (RdgC dimers:DNA§2:1); RdgCK211A started at 1 nM (RdgC 
dimers:DNA§8:1); RdgCE218R and RdgCK227A started at 6 nM (RdgC 
dimers:DNA§30:1) (Figure 4-3 B). 
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Figure 4-4 RdgC binds dsDNA 
A. EMSA assays showing dsDNA binding of wild type RdgC and RdgC mutants with 
mutation at the horseshoe interface. DNA substrate was RGL13/17 (49 bp), at 0.2 nM. 
Protein concentrations: Lane 1, 0 nM; Lane 2, 5.92 nM; Lane 3, 23.68 nM; Lane 4, 
1850 nM. RdgCH222A and RdgCK211A had similar shift pattern to the one of RdgCQ212A; 
RdgCK227A had similar shift pattern to the one of RdgCE218R. 
B. Binding isotherm for dsDNA binding (RGL13/17) of the RdgC proteins, assembled 
from at least 2 EMSAs. For the reactions, 0.2 nM RGL13/17 was used and the protein 
titrations were at 0, 0.37, 0.74, 1.48, 2.96, 5.92, 11.84, 23.68 and 1850 nM. The error 
bars stand for standard deviation of each value point. 
WT 
1 2 3 4
B 
A 
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4.2.5 Circular DNA binding assays 
Circular DNA binding assays were performed on 1% agarose gels. A 3000 bp 
dsDNA plasmid, pGEM-7zf(+) (Promega), was selected as DNA substrate at a 
fixed concentration value of 4.0 ng/ȝl. The plasmid DNA was mixed with 
RdgC protein at 0, 2.3, 4.6, 9.2, 18.5, 37.0, 74.0, 148 and 1590 ng/ȝl. Note the 
several weak bands on top of the single sharp strong band in each lane, 
including the lane free of protein. This was due to the different conformations 
the plasmid adopted in the reaction buffer, which led to the different migration 
rates seen on the agarose gels (Figure 4-5). 
 
 
 
 
Every horseshoe interface mutant was able to slow the migration rate of 
pGEM-7zf(+) (Figure 4-5). The data were not quantified due to the limited 
accuracy of the stain method used and the different conformations the plasmid 
Figure 4-5 RdgC binds circular DNA 
The DNA substrate was pGEM-7zf(+) at 4.0 ng/ȝl. RdgC protein concentrations at Lane 1-
Lane 4 were 0, 18.5, 74 and 1590 ng/ȝl, respectively. 
Unbound DNA 
Bound DNA 
WT
Q212A 
(K211A)
(H222A) 
(K227A) 
E218R 
1 2 3 4 1 2 3 4 1 2 3 4 
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adopted in the reaction buffer. However, it is clear that the mutations did not 
appear to affect circular DNA binding of RdgC to a very large extent.  
 
4.3 in vivo synthetic lethality assays 
The in vitro analyses revealed that the mutant protein retained the ability to 
bind DNA. To investigate whether they also retain the ability to function in 
vivo, I introduced the mutations into the E. coli chromosome at the native site, 
and exploited a synthetic lethality assay to examine their ability to function. 
The assay used an unstable lac+ plasmid, pRC7, carrying a wild type gene of 
interest to cover a deletion allele in the chromosome of a lac- strain. If any 
further mutation is lethal with the covered mutation, plasmid-free segregants 
fail to grow and only plasmid carrying cells forming blue colonies are seen on 
an indicator plate containing IPTG and X-gal. IPTG induces the expression of 
the lac operon on the pRC7 plasmid, and the expression product digests X-gal 
on the plate, transforming the cells having the plasmid to blue. If the further 
mutation is not lethal with the covered mutation, plasmid free segregants form 
healthy white (lac-) colonies. The method details can be found in (Mahdi et al., 
2006) and in Materials and Method, section 2.2.10. 
It is known that deletion of rdgC is synthetically lethal in strains with problems 
in DNA replication restart systems, such as priA-, priA- dnaC810 and priA-, 
dnaC809,820 priC-  strains (See section 1.5.1 for details). Therefore, a pRC7 
derivative that harbours a wild type copy of priA (pAM374) was introduced 
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into strains with the genotype and the wild type rdgC gene then replaced with 
the mutant allele in question to reveal the in vivo functions of each mutant 
RdgC. 
Nonetheless, problems caused by impaired DNA repair systems can often be 
attenuated by slow growth conditions on minimal medium. I therefore also 
tested all the mutants under this condition. 
4.3.1 Strains construction 
The three strains for the assays: priA-, priA- dnaC810 and priA-, dnaC809,820 
priC
-, each carrying pAM374, were first deleted for rdgC using a ¨rdgC::dhfr 
(or ¨rdgC2::dhfr) allele, which encodes a trimethoprim resistance protein. 
Thereafter, they were transduced with P1 phage grown on strains carrying the 
mutant rdgC gene in question located very tightly to a downstream cat cassette 
encoding resistance to chloramphenicol. Cmr transductants were purified and 
checked to confirm that they were sensitive to trimethoprim, but resistant to 
chloramphenicol, i.e. the ¨rdgC::dhfr (or ¨rdgC2::dhfr, where appropriate) 
allele had been replaced by the cat linked mutant rdgC gene encoding the 
protein of interest. Wild type rdgC linked to cat was also transduced in the 
same way for positive controls.  
4.3.2 RdgC mutants in priA- strains 
For convention throughout the thesis, a strain with genotypechromosome 
harbouring a pRC7 derivative carrying a wild type genevector is referred to as 
genevector
+/genotypechromosome. The priA
- lac- strain having pAM374 was thus 
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designated priA+/priA- lac-. Since strains for synthetic lethality assays are 
always lac- in the chromosome, it was omitted in most cases and the strain was 
therefore also known as priA+/priA-.  
The priA+/priA- strain (Figure 1-3, N5972) demonstrated the severe problems 
encountered by the cells without PriA with predominant solid blue colonies 
and a small number of tiny white colonies on LB indicator plates. This 
remaining viability was susceptible to further deletion of rdgC in the 
chromosome, as demonstrated by priA+/priA- rdgC-, with only solid blue 
colonies viable (Figure 4-5, AM1918). The genes carrying mutant rdgC were 
transduced into priA+/priA- rdgC-. The wild type rdgC gene was also 
transduced for positive control (Figure 4-6, YJ047). After 2 days of growth on 
X-gal IPTG LB plates, none of the horseshoe interface mutants appeared to be 
able to substitute for wild type RdgC  in the priA+/priA- strains (Figure 4-6 A), 
indicating that they had a reduced capacity to function in vivo. 
Since such morbidity caused by abnormal DNA replication restart machinery 
may be alleviated under slow growth conditions, the same mutant strains were 
also examined on minimum media supplemented with X-gal and IPTG. After 3 
days of 37 ºC incubation, the positive control YJ047 did produce relatively 
more white colonies with improved health (54% of overall colonies were 
white), despite their smaller overall sizes than their LB media cultured 
counterparts (Figure 4-6 B, YJ047). 
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Figure 4-6 Synthetic lethality assays in priA+/priA- for the horseshoe interface mutants. On the 
top of each picture are numbers and genotypes of the strains; on the bottom are numbers 
indicating the fraction of white colonies. The actual numbers of white/total colonies are shown 
in parentheses. This convention is adopted in the ensuing figures. 
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimum media containing X-gal and IPTG 
The circular figure on the bottom, right to AM1846 is a magnification showing tiny white 
colonies on the plate, as indicated by red arrows. 
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Interestingly, the horseshoe interface mutants showed different levels of 
capacity to substitute for wild type RdgC under these conditions of slower 
growth. The inviability seen in priA+/priA- rdgC- could not be rescued by 
RdgCQ212A, RdgCE218R or RdCK227A. RdgCH222A was able to improve viability, 
and a small fraction of tiny white colonies (24% of white + blue) emerged after 
3 days of growth. RdgCK211A was found to function as well as the wild type 
protein. The growth of the white colonies was almost as good as the wild type 
in terms of both size and number of colonies (53% in rdgCK211A, 54% in 
rdgCWT were white colonies) (Figure 4-6 B). This ability of the K211A mutant 
protein shows some activity relative to the other mutants as it is clearly no 
better at binding DNA than for instance RdgCQ212A or RdgCH222A. The failure 
of RdgCK227A and RdgCE218R to function is not surprising given the reduced 
affinity for DNA oligos (Figures 4-3 and 4-4). 
4.3.3 RdgC mutants in priA- dnaC810 strains 
A priA null strain is very sick due to its inability to load DnaB at stalled or 
rescued replication forks. However, a dnaC810 mutation overcomes this by 
means which are not fully understood, but which permit DnaB loading in the 
absence of PriA. In a synthetic lethality assay, this is reflected in improved 
growth of white colonies (compare strain YJ048 in Figure 4-7 A with strain 
YJ047 in Figure 4-6 A). However, dnaC810 cannot rescue cells lacking both 
PriA and RdgC (Figure 4-7 A, AM1919). Thus, priA- dnaC810 cells provide a 
very sensitive assay for RdgC activity. 
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0.57(932/1624) 
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0.58(449/772) 
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0.58(708/1228) 
0.64(477/743) 
0.74(233/313) 
0.61(395/645) 
A 
B 
Figure 4-7 Synthetic lethality assays in priA+/priA- dnaC810 for the horseshoe interface 
mutants.  
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimum media containing X-gal and IPTG 
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In this assay, RdgCK211A, and RdgCH222A to a lesser extent, were able to 
substitute for wild type RdgC to allow growth of plasmid-free segregants 
(white colonies) on LB indicator plates (Figure 4-7 A).  
Rather strikingly, the segregation of healthy white colonies revealed that RdgC 
is not required to maintain the viability of priA- dnaC810 cells on minimal 
medium (Figure 4-7 B, AM1919). It is therefore not surprising that constructs 
expressing any one of the six mutant RdgC proteins segregate healthy white 
colonies, i.e. the assay on minimal agar is non-informative in this case. 
4.3.4 RdgC mutants in priA- dnaC809, 820 priC- strains 
As described earlier, dnaC809,820 is a super-suppressor of priA- that enables it 
to grow without PriC, provided RdgC is present (Figure 1-3; R. G. Lloyd, 
unpublished). On LB indicator plates, a priA+/priA- dnaC809,820 priC- 
construct segregates solid blue colonies accompanied by smaller white colonies. 
However, without wild type RdgC present, it forms only blue colonies (Figure 
4-8 A, strain AM2046 and YJ026). The same is true on minimal indicator 
medium (Figure 4-8 B). 
All of the horseshoe interface mutants appeared to have little activity in this 
background, behaving much the same as in a priA+/priA- background (compare 
Figure 4-8 A with Figure 4-6 A). The strain encoding RdgCK211A (YJ027) 
produces some white colonies (12%, compared with 44% with wild type RdgC, 
but these are extremely tiny, Figure 4-7 A). Again, as with the constructs in the 
priA
+/priA- background (Figure 4-6 B), the RdgCK211A and RdgCH222A proteins 
showed some activity in the priA+/priA- dnaC809,820 priC background when  
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0.00(0/266) 
A 
B 
Figure 4-8 Synthetic lethality assays in priA+/priA- dnaC809,820 for the horseshoe interface 
mutants.  
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimum media containing X-gal and IPTG 
 
The circular figure right to YJ047 is a magnification showing tiny white colonies on the plate, 
as indicated by red arrows. 
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plated on minimal agar (Figure 4-8 B), but none of the others showed any 
activity. 
4.4 Discussion 
4.4.1 Some mutations at the horseshoe interface negatively 
affected RdgC ability to bind DNA 
Wild type RdgC is able to bind ssDNA, dsDNA and circular plasmid DNA 
substrates with high affinities. Binding is weakened by some of the mutations 
of conserved residues at the horseshoe interface. Wild type RdgC and most of 
the mutants represented a sigmoidal binding curve in dsDNA and ssDNA 
binding assays, indicating some level of cooperativity of DNA binding. The 
non-sigmoidal binding curves of RdgCK227 and RdgCE218R to ssDNA (Figure 4-
3) and RdgCK227 to dsDNA (Figure 4-4) should be dealt with with care, since 
the data for the mutants were not comprehensive enough to draw a faithful 
binding curve. In fact, Moores research suggested a very weak cooperative 
DNA binding of RdgC by using a Scatchard plot of binding (Moore, 2002). 
Similar situations were found for most of the rest of the mutants and will not be 
iterated. 
The change in E218 or K227 appeared to have the most severe effect, with 
much reduced affinity for ssDNA and dsDNA. Nevertheless, both of the 
mutants were still able to bind ssDNA and dsDNA at high concentrations. 
However, there were obvious smears sometimes observed tailing the high 
concentration protein shift bands (Figure 4-3 A, E218R and data not shown). 
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This is a sign of unstable protein:DNA contact that caused continuous 
dissociation when the complex was shifting in the gel. This suggests the two 
residues are important to hold the horseshoe tightly, which is crucial for linear 
oligo binding.  
 The change in Q212 or H222 (RdgCQ212A and RdgCH222A) did not appear to 
disturb RdgCs DNA binding ability in all three experiments. It appears that 
Q212 is not as predicted to interact with E218 and K227 to form triads and the 
two H222 do not form a hydrogen bond, the interactions are less important for 
DNA binding than expected, or the assays failed to detect the existing DNA 
binding defect brought by Q212A and H222A.  
The mutation on K211 slightly reduced RdgCs affinity for dsDNA and ssDNA, 
indicating the residue is hardly involved in the DNA backbone contact. 
It is also worth to note that no gradual change in ssDNA binding assays was 
observed from 1 bound dimer per DNA molecule to 2 dimers per DNA 
molecule, as I saw in dsDNA binding assays (compare Figure 4.3 A to Figure 
4.4 A). It is therefore possible that the slower migration rate was due to 3 or 
more dimers complexed with 1 DNA molecule. However, the shift and the 
minimum length requirement for stable ssDNA binding (23 nt, Moore et al., 
2003) support that the higher molecular weight species reflects 2 dimers 
complexed with 1 DNA molecule. This is also applied to the rest of the 
mutants described in following two chapters. 
Circular DNA binding did not appear to be much affected by the horseshoe 
interface mutations. Taken together with the ssDNA and dsDNA assays, it 
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appears that the instability with short linear oligos is because the dimer ring 
with the mutations could not bind tightly and easily slide off the oligos. Once 
they attach to circular DNA, they move freely along it like beads on a necklace. 
 
4.4.2 The mutations at the horseshoe interface interrupted 
RdgC’s in vivo functions 
In all the three strain backgrounds tested, priA+/priA- (YJ047) and priA+/priA- 
dnaC810  (AM2046) appeared to provide the most stringent test of RdgC 
activity.  
From the assays with these strains, it could be concluded that the Q212, E218 
and K227 substitutions inactivated RdgCs ability to support growth of the 
disabled strains. RdgCH222A did retain some function, but it was so weak that in 
most conditions tested the strain having it either had no improvement or 
improved only slightly. RdgCK211A was surprisingly to be the best able to 
support growth, given its medium rank in the in vitro DNA binding assays 
(4.4.1). However, even this protein is clearly not fully functional.  
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Chapter 5 
The gate interface 
5.1 Background 
The gate interface is supposed to be held together primarily by hydrophobic 
interactions by sitting a phenylalanine (F120) residue from one monomer into a 
hydrophobic pocket on the other monomer. An additional hydrogen bond 
formed between R118 from each monomer completes the interface (Figure 5-1). 
This is different from the way the horseshoe interface is maintained. This 
asymmetry might imply different functionalities of the two interfaces. 
This chapter focuses on the studies on the gate interface. 
5.2 In vitro DNA binding assays 
5.2.1 Mutant design 
RdgCF120S and RdgCF120T were constructed to disrupt the hydrophobic 
interactions that are postulated to hold the gate interface closed. RdgCR118A and 
RdgCR118C were designed in the hope to study the function of the hydrogen 
bond at the interface by either losing it (RdgCR118A), or further strengthening it 
(RdgCR118C). The cysteine residues introduced in both side chains were 
expected to form a disulphide bond, a covalent interaction which is more stable 
than the wild types hydrogen bond. R118åC, F120åT double mutant was 
also generated to better understand the hydrophobic interactions. 
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5.2.2 Cloning, overexpression and purification 
The pYJ001 or pGS853 derivatives having the mutations of interests were 
designed and created as described in Section 2.2.7. Overexpression and 
purification of the proteins were performed as for the horseshoe interface 
mutants (4.2.2.2, 4.2.2.3) (Figure 5-2). 
 
 
 
Figure 5-1 Ribbon diagram illustrating the gate interface of RdgC dimer and the residues 
participated in mutant studies. Residues shaded in red are F120; residues shaded in blue are 
R118. 
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Figure 5-2 12.5% SDS-Page gels showing purified mutant RdgC proteins with E. coli native 
RdgC 
Lane 1, Molecular weight markers; Lane 2, wild type RdgC; Lane 3-7, RdgC proteins with 
mutations as labelled. RCFT=R118C·F120T. 
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5.2.3 Single-stranded DNA binding assays 
As for the horseshoe interface mutants, the assays were done on RGL13, a 49 
nt ssDNA (4.2.3). 
Removing the hydrogen bond by R118A, and the R118C disulphide bond did 
not seem to affect RdgCs ssDNA binding (Figure 5-3). The mutations in F120 
(F120T, F120S) severely damaged its ssDNA binding (Figure 5-3). Only at 
their high concentration did RdgCF120T and RdgCF120S show a sign of DNA 
binding, but also accompanied by massive dissociations (Figure 5-3 A).  
However, this defect could probably be overcome by the additional R118C 
disulphide bond (Figure 5-3 A R118C·F120T). The protein with double 
mutations formed sharp band with the ssDNA on the gel, suggesting the 
protein:DNA complex was very stable. The binding isotherm also showed an 
obvious sign of ssDNA binding improvement (Figure 5-3 B). Nonetheless, its 
slightly weaker affinity indicates that the disulphide bond could not fully 
recover the loss of the gate interface hydrophobic interactions. To be specific, 
wild type RdgC, RdgCR118C, RdgCR118A and RdgCR118C·F120T started to shift 0.2 
nM RGL13 at 1 nM (~5 RdgC dimers per DNA molecule); RdgCF120T and 
RdgCF120S barely started at 20 nM (~100 RdgC dimers per DNA molecule) 
(Figure 5-3 B). 
91 
 
 
 
 
Figure 5-3 RdgC binds ssDNA 
A. EMSAs showing ssDNA binding of wild type RdgC and the gate interface mutants. DNA 
substrate was RGL13 (49 nt), at 0.2 nM. Protein concentrations: Lane 1, 0 nM; Lane 2, 
5.92 nM; Lane 3, 23.68 nM; Lane 4, 1850 nM. RdgCR118A had similar shift pattern to the 
one of RdgCR118C; RdgCF120S had similar shift pattern to the one of RdgCF120T. 
B. Binding isotherm for ssDNA binding (RGL13) of the RdgC proteins, assembled from 3 
EMSAs. For the reactions, 0.2 nM RGL13 was used and the protein titrations were at 0, 
0.37, 0.74, 1.48, 2.96, 5.92, 11.84, 23.68 and 1850 nM. 
B 
A 
Unbound ssDNA 
ssDNA:(1xRdgC dimer) 
ssDNA:(2xRdgC dimer) 
WT 
1 2 3 4
R118C·F120T 
1 2 3 4 1 2 3 4
R118C 
(R118A) 
1 2 3 4
F120T 
(F120S) 
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5.2.4 Double-stranded DNA binding assays 
As for the horseshoe mutants, the assays were done on RGL13/17 (4.2.4). 
All the gate mutants showed similar preference for dsDNA as for ssDNA. 
Neither the elimination of the gate hydrogen bond (RdgCR118A) nor its 
replacement with a disulphide bond (RdgCR118C) showed any obvious effect on 
dsDNA binding. The mutations in F120 (RdgCF120T and RdgCF120S) proved to 
be detrimental to dsDNA binding. As expected, the R118C disulphide bond 
helped improve RdgCF120T dsDNA binding, and RdgCR118C·F120T only showed a 
moderately decreased affinity for dsDNA (Figure 5-4 and 5-5). 
WT 
1 2 3 4
R118C·F120T 
1 2 3 4 1 2 3 4
R118C
(R118A) 
1 2 3 4
F120T 
(F120S) 
Figure 5-4 EMSA assays showing dsDNA binding of wild type RdgC and RdgC mutants with 
mutation at the gate interface.  
 
DNA substrate was RGL13/17 (49 bp), at 0.2 nM. Protein concentrations: Lane 1, 0 nM; Lane 
2, 5.92 nM; Lane 3, 23.68 nM; Lane 4, 1850 nM. RdgCR118A had similar shift pattern to the one 
of RdgCR118C; RdgCF120S had similar shift pattern to the one of RdgCF120T. 
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 To be specific, wild type RdgC and RdgCR118C·F120T started to shift 0.2 nM 
RGL13/17 at 0.3 nM (~2 RdgC dimers per DNA molecule); RdgCR118C started 
at 1 nM; RdgCR118A started at 1.5 nM; RdgCF120T and RdgCF120S barely started 
at 10 nM (~60 RdgC dimers per DNA molecule) (Figure 5-5 B).            
 
5.2.5 Circular DNA binding assays 
As in 4.2.5, the assays used the 3000 bp pGEM-7zf(+) as the DNA substrate at 
a fixed concentration value of 4.0 ng/ȝl. The plasmid DNA was mixed with 
RdgC protein at 0, 18.5, 74.0 and 1590 ng/ȝl (Figure 5-6).  
Similar to the results in 4.2.5, the effects on circular DNA binding of the 
mutations at the gate interface were not obvious. Even with much impaired 
affinity for short linear oligos, RdgCF120T and RdgCF120S could still make stable 
contact with the plasmid DNA, making sharp shift bands on the gel (Figure 5-
Figure 5-5 Binding isotherm for dsDNA binding (RGL13/17). 
Data were assembled from 3 EMSAs. For the reactions, 0.2 nM RGL13/17 was used and the
protein titrations were at 0, 0.37, 0.74, 1.48, 2.96, 5.92, 11.84, 23.68 and 1850 nM. 
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6). The additional R118C disulphide bond did not alter the proteins affinity for 
the plasmid DNA to any obvious extent. 
 
 
 
 
5.3 in vivo synthetic lethality assays 
As in 4.3, all the gate interface mutants were tested for their in vivo activity in 
strains using synthetic lethality constructs of the three genotypes. 
5.3.1 RdgC mutants in priA- strains 
None of the gate mutants were able to substitute for wild type RdgC in the 
strain background on LB indicator plates, since plasmid-free segregants were 
inviable (no white colonies; see Figure 5-7 A). This is almost also true on 
minimal agar, where most of the mutants did not segregate any white colonies 
(Figure 5-7 B). However, RdgCR118C and RdgCR118A were able to substitute for 
wild type RdgC in this strain background on minimal agar, reflected by white 
Figure 5-6 RdgC binds circular DNA 
The DNA substrate was pGEM-7zf(+) at 4.0 ng/ȝl. Protein concentrations at Lane 1-Lane 4 were 
0, 18.5, 74 and 1590 ng/ȝl, respectively. 
WT (F120S) 
F120T 
Unbound DNA 
Bound DNA 
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
R118C·F120T
R118C 
(R118A) 
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colonies similar to the wild type on minimal indicator plates (Figure 5-7 B, 
AM1843 and AM1848). This could suggest that only under slow growth 
conditions can these two mutants function as wild type RdgC in this strain 
background; this function is lost if the cells are under stressful DNA repair 
pressure in fast growth conditions. 
5.3.2 RdgC mutants in priA- dnaC810 strains 
In this strain background, only RdgCR118C and RdgCR118A mutants segregated 
white colonies on LB indicator plates. Nonetheless, given the number of the 
white colonies and the white sectors circling the blue colonies, the mutants 
appeared to be fully functional in priA- dnaC810 strain background (Figure 5-8 
A, AM1853 and AM1858). 
Similar to 4.3.3, this strain background did not yield informative data on the in 
vivo function of the mutants under slow growth conditions, as all constructs 
segregated white colonies on minimal indicator plates (Figure 5-8 B). 
5.3.3 RdgC mutants in priA- dnaC809, 820 priC- strains 
Very similar to the scenario seen in a priA+/priA- background, all the tested 
gate interface mutants (RdgCR118C, RdgCR118A, RdgCF120T, RdgCF120S and 
RdgCR118C·F120T) failed to substitute for wild type RdgC in priA
- dnaC809,820 
priC
- background on LB indicator plates (compare Figure 5-7 A with Figure 5-
9 A). Only the strains encoding RdgCR118C (YJ033) and RdgCR118A (AM2049) 
developed white colonies on minimal indicator plates (Figure 5-9 B).  
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B 
Figure 5-7 Synthetic lethality assays in priA+/priA- for the gate interface mutants.  
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimal media containing X-gal and IPTG 
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Figure 5-8 Synthetic lethality assays in priA+/priA- dnaC810 for the horseshoe interface 
mutants.  
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimal media containing X-gal and IPTG 
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Figure 5-9 Synthetic lethality assays in priA+/priA- dnaC809,820 for the gate interface 
mutants.  
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimal media containing X-gal and IPTG 
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5.4 Discussion 
5.4.1 The hydrophobic interactions are crucial for DNA binding  
The DNA binding assays on the gate interface mutants revealed the key role of 
the hydrophobic interactions in RdgCs DNA binding activity. Both of the 
mutants (RdgCF120T and RdgCF120S) lost stable contact with ssDNA and dsDNA. 
The other force that helps hold together the gate interface is the hydrogen bond 
formed between R118 from each side chains. Neither its removal (RdgCR118A) 
nor replacement by a disulphide bond (RdgCR118C) appeared to affect its DNA 
binding in any aspect. It is thus possible that the R118 hydrogen bond is not 
critical for holding the dimer interface shut. 
An artificial gate interface was made by replacing the hydrophobic interactions 
with a disulphide bond (RdgCR118C·F120T). This mutant had an obvious but only 
moderate decrease of binding on short DNA oligos (5.2.3 and 5.2.4). 
Compared to RdgCF120T, the added disulphide bond clearly improved its DNA 
binding; but its relatively weak binding indicates it could not fully substitute 
for the gate interface hydrophobic interactions. Another possibility is that the 
two C118 did not interact to form a disulphide bond as predicted. The 
enhanced affinity for some DNA structures could reflect an improvement in the 
gate strength; but this might attribute to a more hydrophobic environment 
brought by the R118C, rather than a disulphide bond.  
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5.4.2 The mutations at the gate interface interrupted RdgC’s in 
vivo functions 
The removal of the gate interface hydrophobic interaction (F120T and F120S) 
was clearly destructive to the proteins function, as the mutant proteins could 
not substitute for wild type RdgC in in vivo assays (5.3). The changes in the 
gate interface hydrogen bond, however, were less destructive to its in vivo 
function. When cells were under limited pressure (e.g. on minimal media, or in 
priA
- dnaC810), the loss/stronger-replacement of the R118 hydrogen bond did 
not develop any obvious difference from the wild type. Only in cells under 
serious pressure did the defect of the changes in the R118 hydrogen bond 
emerge (e.g. in priA- or priA- dnaC809,820 priC-). This suggests some special 
functionality lying in the hydrogen bond. 
Although the R118C disulphide bond could help recover DNA binding of 
RdgC with interrupted gate hydrophobic interactions (RdgCR118C·F120T, see 
5.4.1), its assistance in vivo was insubstantial. This again reinforces the idea 
that the gate interface hydrophobic interactions are vital for the proteins 
functionality. 
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Chapter 6 
The finger domains 
6.1 Background 
The finger domains consist of two anti-parallel Į helices that project 
perpendicular to the ring on either side of the dimer interface at the gate 
(Figure 6-1). They span from S77 to L115. These domains are special because: 
a) they have high B factors in the crystal structure; b) a high proportion of 
conserved lysines on the fingers cause a highly electropositive upper surface 
and a basic tip at the turn of the two anti-parallel helices. The questions to this 
point are: do the finger domains assist DNA binding, and do they possess any 
other functions?  
This chapter attempts to find the answers by using the same in vitro and in vivo 
assays as used for the interfaces. 
6.2 In vitro DNA binding assays 
6.2.1 Mutant design 
Since the finger domains are not part of the dimer ring structure, the complete 
deletion of them is not supposed to largely affect the protein folding. RdgC¨F 
was made by changing P76 to glycine and L116 to threonine, and the residues 
in between deleted. Because some of the altered residues are components of the 
hydrophobic pocket that helps hold together the gate interface (3.4), the R118C 
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disulphide bond was also created together with the finger deletion to achieve an 
artificial gate lock (RdgC¨F·R118C). 
Given the flexibility and highly electropositive charge of the finger domains, 
they are hypothetically involved in RdgCs first touch on its binding substrates. 
The frontier is the basic fingertip, consisting of an arginine (R97) and three 
lysines (K98, 100, 101). I therefore hoped to reveal the functionality of the 
finger domains by RdgCFTM (FTM stands for Finger Tip Mutations; they are 
R97S, K98Q, K100Q and K101E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gate 
Finger 
Gate 
A B
Finger 
R97
K98
K100
K101
C 
Figure 6-1 Overall structure of RdgC showing the three different domains and one of its finger 
tips 
A. Ribbon diagram showing the ring structure of the dimer. 
B. Rotated ribbon diagram showing the finger domains 
C. An electrostatic surface representation showing the four basic residues involved in the
mutant assays. 
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6.2.2 Cloning, overexpression and purification 
The pYJ001 or pGS853 derivatives having the mutations of interests were 
designed and created as described in Section 2.2.7. Overexpression and 
purification of the proteins were performed as for the horseshoe interface 
mutants (4.2.2.2, 4.2.2.3) (Figure 6-2). RdgC¨F and RdgC¨F·R118C showed a 
much decreased affinity for the heparin column (Appendix 1). 
 
 
 
 
6.2.3 Single-stranded DNA binding assays 
As for the horseshoe interface mutants, the assays were done on RGL13, a 49 
nt linear ssDNA (4.2.3). 
Figure 6-2 12.5% SDS-Page gels showing purified mutant RdgC proteins with E. coli native 
RdgC 
Lane 1, Molecular weight markers; Lane 2, wild type RdgC; Lane 3-5, RdgC proteins with 
mutations as labelled. FTM=Finger Tip Mutation. 
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The finger domains are crucial for ssDNA binding, as the deletion of the whole 
region (RdgC¨F) almost completely abolished the proteins ssDNA binding 
activity (Figure 6-3). Only at the highest concentration (RdgC dimers:DNA 
§10,000:1) did RdgC¨F barely blur the DNA band. The R118C disulphide bond 
was able to bring back some of the binding activity, the level of which was 
however quite limited (Figure 6-3, RdgC¨F·R118C). Altering the charge of the 
finger tips (RdgCFTM) had a major effect on ssDNA binding too; but the mutant 
was able to shift the DNA as a band (Figure 6-3 A, FTM), although there was 
still smear tailing it. To be specific, wild type RdgC showed signs of shift at 1 
nM (RdgC dimers:DNA§4:1); RdgCFTM started at 20 nM (RdgC 
dimers:DNA§100:1); RdgC¨F and RdgC¨F·R118C only shifted the DNA at the 
highest concentration (Figure 6-3 B). 
 
6.2.4 Double-stranded DNA binding assays 
As for the horseshoe mutants, I used RGL13/17 as the substrate for the assays 
(4.2.4). 
RdgC with its whole finger domains deleted (RdgC¨F) did not show any 
obvious sign of dsDNA binding activity. Interestingly, albeit with very weak 
and unstable ssDNA binding activity, RdgC¨F·R118C and RdgCFTM retained 
moderate level of dsDNA activity and both made sheer shifts at high 
concentrations (Figure 6-4 A). The isotherms of the mutants suggested an 
energy hurdle when binding to dsDNA; but once the hurdle was overcome, the 
mutants could make stable contact with the dsDNA.  
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Figure 6-3 RdgC binds ssDNA 
A. EMSA assays showing ssDNA binding of wild type RdgC and the finger mutants. DNA 
substrate was RGL13 (49 nt), at 0.2 nM. Protein concentrations: Lane 1, 0 nM; Lane 2, 
5.92 nM; Lane 3, 23.68 nM; Lane 4, 1850 nM.  
B. Binding isotherm for ssDNA binding (RGL13) of the RdgC proteins, assembled from at 
least 2 EMSAs. For the reactions, 0.2 nM RGL13 was used and the protein titrations were 
at 0, 0.37, 0.74, 1.48, 2.96, 5.92, 11.84, 23.68 and 1850 nM. The error bars stand for 
standard deviations of each value point.  
B 
A 
Unbound ssDNA 
ssDNA:(1xRdgC dimer) 
ssDNA:(2xRdgC dimer) 
WT 
1 2 3 4
1 2 3 41 2 3 4
FTM 
1 2 3 4 
¨F ¨F·R118C
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Figure 6-4 RdgC binds dsDNA 
A. EMSA assays showing dsDNA binding of wild-type RdgC and RdgC mutants with 
mutation at the fingers. DNA substrate was RGL13/17 (49 bp), at 0.2 nM. Protein 
concentrations: Lane 1, 0 nM; Lane 2, 5.92 nM; Lane 3, 23.68 nM; Lane 4, 1850 nM.  
B. Binding isotherm for dsDNA binding (RGL13/17) of the RdgC proteins, assembled 
from at least two EMSAs (except for ¨F). For the reactions, 0.2 nM RGL13/17 was 
used. The protein titrations of WT and ¨F were at 0, 0.37, 0.74, 1.48, 2.96, 5.92, 11.84, 
23.68 and 1850 nM. The titrations of ¨F·R118C and FTM were at 0, 9.25, 18.5, 37, 74, 
148, 296, 592 and 1850 nM. The error bars stand for the standard deviation of each 
value point (except for ¨F). 
B 
WT 
1 2 3 4
A 
1 2 3 41 2 3 4 1 2 3 4 
FTM ¨F ¨F·R118C
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To be specific, wild type RdgC showed signs of shift at 0.5 nM (~2 RdgC 
dimers per DNA molecule); RdgCFTM and RdgC¨F·R118C started at 40 nM (~200 
RdgC dimers per DNA molecule); RdgC¨F only shifted the DNA at the highest 
concentration (Figure 6-4 B). 
6.2.5 Circular DNA binding assays 
As in 4.2.5, the assays used the 3000 bp pGEM-7zf(+) as the DNA substrate at 
a fixed concentration value of 4.0 ng/ȝl. The plasmid DNA was mixed with 
RdgC protein at 0, 18.5, 74.0 and 1590 ng/ȝl (Figure 6-5).  
  
 
 
In these assays, the changes introduced in the finger domains of the protein 
showed much reduced circular DNA binding activity. The R118C did not 
deliver any obvious improvement to RdgC¨Fs circular DNA binding.  
RdgC with altered fingertips charge (RdgCFTM) also failed to show much active 
circular DNA binding. Note that the migration speed decreased gradually in a 
Figure 6-5 RdgC binds circular DNA 
The DNA substrate was pGEM-7zf(+) at 4.0 ng/ȝl. Protein concentrations at Lane 1-Lane 4 
were 0, 18.5, 74 and 1590 ng/ȝl, respectively.  
WT 
Unbound DNA 
Bound DNA 
FTM
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
¨F ¨F·R118C 
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very slow but seemingly constant rate as the protein concentration increased. 
This suggests that the amount of the mutant RdgC protein attached to DNA 
was much lower than the one of the wild type protein. However, the 
protein:DNA complex was still stable since the shifted bands were sharp, as 
seen in the wild type protein. 
6.3 in vivo synthetic lethality assays 
As in 4.3, all the finger domain mutants were tested for their in vivo activity in 
strains using synthetic lethality constructs of the three genotypes. 
6.3.1 RdgC mutants in priA- strains 
Using the same synthetic lethality assay described previously, all of the tested 
finger mutants (RdgC¨F, RdgC¨F·R118C and RdgCFTM) failed to produce any 
white colonies on LB or minimal indicator plates (Figure 6-6), suggesting that 
none of them could substitute for wild type RdgC. 
6.3.2 RdgC mutants in priA- dnaC810 strains 
On LB indicator plates, RdgC mutants with the finger domains deleted 
(RdgC¨F and RdgC¨F·R118C) did not appear to substitute for wild type RdgC, 
since plasmid-free segregants were inviable (no white colonies on LB indicator 
plates) (Figure 6-7 A, AM1854 and AM1855). The strain encoding RdgCFTM 
managed to produce a few tiny white colonies, suggesting some limited activity 
retained on the mutant (Figure 6-7 A, AM1949). 
Similar to 4.3.3, the assay on minimal indicator plates is non-informative 
(Figure 6-7 B).
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AM1918 
priA+/priA- rdgC- 
YJ047 
priA+/priA- 
AM1844 
priA+/priA- rdgC¨F 
AM1845 
priA+/priA- rdgC¨F·R118C 
AM1948 
priA+/priA- rdgCFTM 
YJ047 
priA+/priA- 
AM1844 
priA+/priA- rdgC¨F 
AM1948 
priA+/priA- rdgCFTM 
AM1918 
priA+/priA- rdgC- 
AM1845 
priA+/priA- rdgC¨F·R118C 
0.22(127/576) 
0.00(0/485) 
0.00(0/1380) 
0.00(0/1616) 
0.00(0/1276) 
0.54(520/959) 
0.00(0/944) 
0.00(0/768) 
0.00(0/1153) 
0.00(0/559) 
A 
B 
Figure 6-6 Synthetic lethality assays in priA+/priA- for the finger mutants.  
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimal media containing X-gal and IPTG 
 
110 
 
 
YJ048 
priA+/priA- dnaC810 
AM1854 
priA+/priA- dnaC810 
rdgC¨F 
YJ048 
priA+/priA- dnaC810 
0.73(212/291) 
0.00(0/643) 
0.00(0/573) 
0.00(0/655) 
0.21(210/1020) 
0.79(330/416) 
0.58(449/772) 
0.65 (183/280) 
0.57(354/626) 
0.72(522/727) 
A 
B 
Figure 6-7 Synthetic lethality assays in priA+/priA- dnaC810 for the finger mutants.  
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimal media containing X-gal and IPTG 
 
The circular pictures are magnifications of sections as indicated by gray arrows. 
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priA+/priA- dnaC810 
rdgC- 
AM1855 
priA+/priA- dnaC810 
rdgC¨F·R118C 
AM1949 
priA+/priA- dnaC810 
rdgCFTM 
AM1919 
priA+/priA- dnaC810 
rdgC- 
AM1854 
priA+/priA- dnaC810 
rdgC¨F 
AM1855 
priA+/priA- dnaC810 
rdgC¨F·R118C 
AM1949 
priA+/priA- dnaC810 
rdgCFTM 
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6.3.3 RdgC mutants in priA- dnaC809, 820 priC- strains 
Similar to the results of the assay in the priA+/priA- background,  all the finger 
mutants (RdgC¨F, RdgC¨F·R118C and RdgCFTM) failed to substitute for wild type 
RdgC in priA- dnaC809,820 priC- background on LB indicator plates (compare 
Figure 6-6 A with Figure 6-8 A).  
Again, as with the constructs in the priA+/priA- background (Figure 6-6 B) 
RdgC¨F and RdgC¨F·R118C still could not deliver any activity in the strain 
background on minimal agar (Figure 6-8 A, YJ034 and YJ035). However, the 
strain encoding RdgCFTM behaved differently, as it produced a few small white 
colonies (Figure 6-8 B, YJ038, compared to Figure 6-6 B, AM1948). Although 
the small size and number of the white colonies suggest poor viability of the 
plasmid-free segregants, it proved once again RdgCFTM did retain some level of 
functionality.
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AM2046 
priA+/priA- priC- 
 dnaC809, 820 
YJ034 
priA+/priA- priC- 
dnaC809,820 rdgC¨F 
0.44(275/623) 
0.00(0/557) 
0.00(0/427) 
0.00(0/435) 
0.70(197/278) 
0.00(0/486) 
0.00(0/573) 
0.64 (302/471) 
0.38(196/515) 
A 
B 
Figure 6-8 Synthetic lethality assays in priA+/priA- dnaC809,820 for the gate interface 
mutants.  
A. Synthetic lethality assays on LB media containing X-gal and IPTG 
B. Synthetic lethality assays on minimal media containing X-gal and IPTG 
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dnaC809,820 rdgCFTM 
0.00(0/420) 
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6.4 Discussion 
6.4.1 The finger domains are crucial for DNA binding  
RdgC with its whole finger domains deleted (RdgC¨F) lost most of its DNA 
binding activities. Especially in short linear oligo binding assays, there was 
hardly a sign of DNA shifting (6.2.3 and 6.2.4). Only at very high 
concentration did the mutant manage to make yet very unstable contact with 
the circular DNA, which caused a smear featured shift (6.2.5). 
The additional disulphide bond provided by the R118C (RdgC¨F·R118C) 
improved short linear oligo binding of RdgC¨F, especially on dsDNA, 
suggesting that its inability to bind dsDNA is partially due to the weak link 
between the RdgC¨F gates (6.2.3 and 6.2.4). The improvement on ssDNA was 
limited. Interestingly, there was no sign of improvement regarding to circular 
DNA binding (6.2.5). This suggests a crucial role of the finger domains in 
ssDNA and circular DNA binding. It is also worth noting that the disulphide 
bond might not exist, as mentioned in the previous chapter (Section 5.4); the 
improved gate strength could attribute to a more hydrophobic environment 
brought by the R118C substitution. 
The neutralised finger tips (RdgCFTM) had a moderate negative effect upon 
short linear oligo binding (6.2.3 and 6.2.4). The mutant was still able to make 
stable contact with the duplex, suggesting that the central hole alone is enough 
for binding tightly to dsDNA. However, there appeared to be an obstacle in the 
initial DNA binding; but once the DNA is bound, they form a stable complex. 
This is also probably the case when RdgCFTM binds circular DNA (6.2.5). The 
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only difference was that the obstacle for the mutant to bind circular DNA 
appeared to be more difficult to overcome than when it bound ssDNA or 
dsDNA. 
6.4.2 RdgC’s in vivo functionality was greatly impaired by the 
finger mutations. 
RdgC with finger domain deleted (RdgC¨F) was found to retain little activity in 
all strain backgrounds tested. Its in vivo function was not recovered even with 
improved DNA binding affinity, attributing to the introduced R118C 
disulphide bound (RdgC¨F·R118C). 
A less dramatic change by neutralising the electropositive charge of the 
fingertips (RdgCFTM) also showed a major effect upon its in vivo functionality. 
However, it did retain some activity, which was only detectable in a few 
conditions tested. RdgCFTM was probably the weakest mutant protein so far that 
could substitute for wild type RdgC in vivo, even weaker than RdgCH222A (see 
Chapter 4 for details). 
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Chapter 7 
General discussion 
The work described in this thesis attempted to unfold the role of RdgC with 
structural, biochemical and genetic approaches. Previous studies had pointed 
towards RdgCs involvement with DNA recombinational repair, specifically to 
prevent illegitimate loading of RecA onto dsDNA, thus limiting unnecessary 
exchanges. This idea is supported by three pieces of evidence: 1) RdgC binds 
DNA, with a greater affinity for dsDNA (Moore et al., 2003); 2) in cells with 
defect in DNA replication restart, RdgC was found to prevent RecAs over-
activity (Moore et al., 2003); 3) RdgC has been reported to limit RecA loading 
by substrate competition in vitro (Drees et al., 2006). 
In this work, the RdgC protein of E. coli was overexpressed and purified to 
high quality. It was then crystallised either with or without DNA. It was clear 
that the addition of DNA molecules enhanced the crystal growth. 
Crystallisation in the absence of DNA produced smaller and non-isomorphous 
crystals, and diffracted to only 2.8 Å, which could be enhanced up to 2.4 Å 
when co-crystallised with DNA. The structure of RdgC dimer was identified to 
mimic a ring structure, with two additional fingers attached to the gate 
interface. Biochemical and genetic studies proved that intact dimer interfaces 
and finger domains are necessary for both of its DNA binding activity and its 
functionality in vivo. 
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7.1 Does RdgC bind DNA by encircling it? 
Although the structure of the RdgC dimer was resolved from the RdgC:DNA 
co-crystallisation, the DNA molecule could not be located. This is not 
surprising since RdgC is known for its non-specific preference on structure or 
sequence, with which RdgC is unable to hold DNA in unique position or 
conformation. However, given the size and the positive charge of its inner hole 
(30 Å diameter), it is very likely where RdgC interacts with DNA when they 
form a stable complex. This may also explain why crystallisation without DNA 
did not yield high quality of crystals. RdgC exists in a monomer-dimer 
equilibrium, with a lower percentage of higher-order oligomers also present 
(Tessmer et al., 2005; Drees et al., 2006). The presence of DNA might help 
mediate dimer formation and drive the equilibrium towards dimerisation, a 
possible reason why no monomers were observed in crystals. In fact, the RdgC 
protein appeared to exist only as dimers on the gel-filtration column during 
purification, eluting as a single peak at size corresponding to a dimer. These 
suggest that RdgC exists primarily as a dimer, and monomers rarely occur and 
are transient in the presence of DNA. This also rejects the possibilities 
proposed by Drees, et al., 2006, who concluded RdgC bound DNA with higher 
affinity as a monomer, compared with a dimer, and the protein existed almost 
exclusively as monomers at low concentrations. If they were true, then 
RdgCFTM would not have had trouble to bind linear or circular DNA at low 
protein concentrations, which was disproved by this work. This also makes 
clear that the lower shifts seen in ssDNA and dsDNA binding assays actually 
reflected one dimer bound per one DNA molecule, rather than one monomer 
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bound per one DNA molecule (Figure 4-3), i.e. RdgC binds DNA primarily as 
a dimer. 
Although RdgC has a unique protein fold (Dali server search (Holm and 
Sander, 1993)), there are DNA binding proteins that also adopt a ring structure 
with a positively charged central DNA binding channel. Sliding clamp proteins 
such as PCNA (Krishna et al., 1994) and ȕ clamp (Kong et al., 1992) are such 
examples. Sliding clamps are processivity factors that encircle DNA at 
replication forks. The ȕ clamp of E. coli is a dimer, with each monomer 
containing three domains of identical topology (Figure 7-1 A). The tightly 
closed ring has a 35 Å hole, with the ability to maintain a topological 
interaction with DNA, whilst not directly interacting with it (Kelman and 
O'Donnell, 1995). This allows the ȕ clamp to slide along the replicating DNA 
without limiting the speed of the replisome. In comparison, another toroidal 
protein, the SARS-CoV nsp7-nsp8 hexadecamer (Figure 7-1 B) has similar 
dimensions of the hole (30 Å) to that of RdgC and is supposed to interact 
directly with the backbone of RNA (Zhai et al., 2005). SARS-CoV (Severe 
Acute Respiratory Syndrome Coronavirus) is a positive-stranded RNA virus 
with complex RNA-processing machinery (Gorbalenya, 2001; Snijder et al., 
2003; Thiel et al., 2003), and the SARS protein is thought to act as a 
processivity factor and encircles dsRNA. It is therefore reasonable to propose 
that RdgC encircles and interacts directly with the backbone of dsDNA (25 Å 
diameter) with its positively charged sidechains lining the hole.  
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Figure 7-1 Electrostatic surface representation of a sliding clamp protein and the SARS-CoV 
nsp7-nsp8 hexadecamer (pictures made by Geoff Briggs) 
A.  ȕ clamp 
B. SARS-CoV nsp7-nsp8 
 
The proposed DNA binding channel of RdgC is 40 Å from the front to the back 
of the ring and 55 Å from fingertip to fingertip. This area could interact with 
approximately 18 bp of DNA, agreeing well with the 15-20 bp required to 
make a stable complex in vitro (Moore et al., 2003; Moore et al., 2004). 
However, the fact that the RdgC protein with neutralised or deleted finger tips 
(RdgCFTM and RdgC¨F·R118C) could still make stable contact with dsDNA 
implies that the central hole alone is enough to confer sufficient binding to 
dsDNA (6.2.4). In addition, this model can also answer why RdgC has no 
specific preference on any structure or sequence, and its slightly better affinity 
for dsDNA than ssDNA. It is very likely that the protein is primarily 
interacting with the negatively charged backbone if DNA is bound in the 
central hole. Therefore, as long as the DNA molecule has a region of the 
correct dimensions (a duplex of at least 20 bp), the binding of different 
structures or sequences will be indistinguishable. On the other hand, the 
slightly weaker ssDNA binding might reflect a poor positioning due to a less 
stable contact between the proteins positively charged binding channel and the 
A B
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ssDNA molecules backbone phosphates. It is also worth noting that 
RdgC¨F·R118C and RdgCFTM showed a less stable interaction with ssDNA (6.2.3). 
This might imply that the positively charged fingertips are important to ssDNA 
binding, but not to dsDNA binding. 
7.2 How does RdgC load onto DNA? 
After obtaining the ring structure of RdgC and its proposed DNA binding 
channel, another purpose of this project naturally emerged as to solve how 
RdgC loads onto DNA. 
As proposed in Chapter 4, the RdgC ring may either slide onto DNA ends 
without the need to open either dimer interfaces, or open one or both of them to 
embrace the DNA. However, if RdgC binds DNA primarily as a dimer, it 
then must open at least one of the dimer interfaces to bind to circular DNA.  
The horseshoe interface is held together by hydrogen bonds between the ȕ 
strands and also between the 2 anti-parallel helices on the outer surface. The 
gate interface is held primarily by sitting F120 from one chain into a 
hydrophobic pocket formed by residues from the other chain. A hydrogen bond 
between R118 from each chain completes the interface. The gate interface is 
also winged by two finger domains. This extreme asymmetry between the two 
interfaces outlines potential different functions for the protein, implying that 
only one interface is unlocked for DNA binding. 
In vitro DNA binding assays revealed that the mutations on the conserved 
residues at the horseshoe interface did not seem to affect the proteins circular 
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DNA binding (Chapter 4). This suggests that the protein with impaired 
horseshoe interface was still able to open and close the ring for DNA binding. 
However, some mutants (RdgCE218R and RdgCK227A) had obvious reduced 
affinity for linear oligos. It appears that disrupted horseshoe interface leads to a 
change of the central hole dimension, causing a weakened protein-DNA 
backbone contact and therefore allowing the RdgC ring to slide along DNA 
molecule more easily. This did not affect circular DNA binding presumably 
because they fall off the end of small linear oligos, whereas they move freely 
along circular DNA but stay attached, like beads on a necklace.  
The scenario on the other interface was similar, except that interfering with the 
hydrophobic interactions was even more destructive to the proteins activity on 
short linear oligos and circular DNA binding. This is not surprising as the main 
force to stabilise the gate interface is the hydrophobic interactions, whereas the 
residues substituted at the horseshoe interface are less influential. The R118 
hydrogen bond was proved to be a minor force in maintaining the gate 
interface. 
The question to this point is how RdgC opens which interface(s) for DNA 
binding. Unlike the ȕ clamp protein that relies on a clamp loader protein for 
DNA loading, RdgC has a mechanism of opening the ring by itself. The finger 
domains are a possible candidate for such a role because of their high 
flexibility (reflected by high B factors) and their electropositive potential 
(recognising DNA). This also raises the possibility that RdgC opens the gate 
interface for access to DNA via the assistance of the finger domains in vicinity.  
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Indeed the finger mutants exhibited very different behaviours compared to their 
interfaces counterparts, which would lead the fingers to such a role as the 
RdgC ring loader. The protein with the whole finger domain deleted (RdgC¨F) 
was unable to form stable complex with either short linear oligos or circular 
plasmid molecules. This could be partially because the disrupted hydrophobic 
interactions by the deletion cannot hold together the gate interface, thus losing 
the conformational constraint on the DNA binding. This again proved the 
remaining R118 hydrogen bond alone is not able to hold the gate closed. The 
results from a rather milder mutant with neutralised fingertips (RdgCFTM, see 
Chapter 6) were more interesting. With intact dimer interfaces the mutant could 
still make stable contact with dsDNA similar to the wild type protein. The only 
problem appeared to be a restricted access to dsDNA molecules, as represented 
by a delayed-in-concentration binding isotherm seen in Figure 6-4 B. This 
delay can be explained by the results from circular plasmid DNA binding 
assays, in which the finger tip mutation almost completely abolished the 
proteins binding activity on circular DNA. RdgC¨F·R118C is the only other 
mutant that bound well to dsDNA but poorly to circular DNA. A plausible 
explanation is that both have problems of recognising DNA and opening the 
ring for DNA binding, especially for circular DNA molecules; while short 
linear oligos can find their way to the binding channel by sliding in from either 
DNA end. This would certainly be more difficult than the usual way of loading, 
and results in a shift of the binding curve to higher protein concentrations 
(Chapter 6). It is therefore clear that the electropositive finger domains are 
probably responsible for recognising DNA and opening the gate interface for 
binding DNA, especially circular DNA. Given the fact that disrupted gate 
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interface (F120T and F120S) caused the RdgC:linear DNA complex constantly 
to dissociate, the gate interface is possibly required to close after the protein 
ring accommodating DNA in the central hole for a usual binding. 
Therefore, I propose that RdgC loading onto DNA is normally finger domains 
mediated, which consists of four stages: 1) the finger domains recognise and 
make first contact with target DNA molecules (Figure 7-2 A); 2) then the 
finger domains rotate on binding, which disrupts the F120-mediated interaction 
at the gate interface (Figure 7-2 B); 3) disruption of the interface causes the 
gate to open, and the RdgC can slide over the DNA (Figure 7-2 C); 4) once the 
DNA is properly located in the central binding channel, the finger domain 
rotates back into its original position, the gate closes, and the ring structure is 
reformed (Figure 7-2 D). In this model, RdgC forms a dimer before it 
encounters a DNA molecule, and the horseshoe interface remains linked during 
binding. 
Another possible mechanism for DNA loading may be achieved by DNA 
mediated RdgC dimerisation. Several lines of evidence suggest that RdgC is 
present as monomer, dimer and higher-order oligomers in solution (Tessmer et 
al., 2005; Moore et al., 2003; Drees et al., 2006). It is therefore possible for 
RdgC to attach to a DNA molecule as a monomer on one side, then another 
monomer lands on the DNA properly to complete the binding and protein 
dimerisation. This binding mode can be used to explain the binding pattern of 
RdgCFTM and RdgC¨F·R118C on the circular plasmid DNA (Figure 6-5 FTM and 
¨F·R118C). The gradual minor shifts seen on the gel might be a result from the 
rare occurring DNA mediated RdgC dimerisation. The relatively later shift in 
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RdgC¨F·R118C could be due to its disulphide bond (or improved hydrophobic 
environment, see section 5.4) driving the monomer-dimer equilibrium towards 
the dimer side, thus less monomers are available for DNA mediated 
dimerisation. The weak shifts again proved the very low proportion of the 
monomer species in solution, as proposed in section 7.1. In contrast, RdgC¨F 
could only make a smear shift at the highest protein concentration, a possible 
result from its weak gate interface constantly opening to release bound DNA 
(Figure 6-5 ¨F). 
 
 
Figure 7-2 finger-domain-mediated DNA loading model (pictures made by Geoff Briggs) 
A. The finger domains recognise and make first contact with the target DNA molecule 
B. The finger domains rotate on binding, which disrupts the F120-mediated interaction at the 
gate interface 
C. Disruption of the interface causes the gate to open, and the RdgC can slide over the DNA 
D. Once the DNA is properly located in the central binding channel, the finger domain rotates 
back into its original position, the gate closes, and the ring structure is reformed 
A B
DC 
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In summary, RdgC binds DNA presumably through finger domains-mediated 
DNA loading model. Nonetheless, RdgC could still slide onto its substrates 
without opening the ring when it encounters open DNA ends; or form dimers 
on the target DNA (DNA mediated dimerisation). However, they might rarely 
occur for the wild type protein. 
7.3 What does RdgC do in vivo? 
As is already known, RdgC is hardly found to do anything else other than bind 
to DNA. This special property leads to the idea that RdgC functions in vivo 
mainly as a DNA binding protein. Therefore, it had been expected that weak 
DNA binding RdgC mutants would function poorly in vivo, and vice versa. 
This is generally true as weak DNA binding mutants did not substitute for wild 
type RdgC in all conditions tested, such as RdgCE218R, RdgCK227A, RdgC¨F, 
RdgCF120T and RdgCF120S. However, further analysis of my data reveals that 
different RdgC mutants exhibited preference for different DNA substrates. In 
general, the interfaces mutants favoured circular plasmid DNA, whereas some 
finger mutants (RdgC¨F·R118C and RdgCFTM) had a preference towards short 
linear oligos. The question is therefore affinity for which DNA species is 
linked to RdgCs activity in vivo, and why. Furthermore, strong evidence 
supports that the RdgC ring opens when loading onto DNA, and closes 
afterwards (refer to the finger domains-mediated DNA loading model, see the 
previous section for details); but it did not exclude the sliding-on and DNA-
mediated dimerisation mode. A question could be asked as to which occurs for 
RdgCs in vivo functionality. Last but not the least, if RdgC acts in vivo purely 
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as a DNA binding protein, then mutants that retain good DNA binding affinity 
(such as RdgCH222A, RdgCQ212A, RdgCR118A and RdgCR118C) would be expected 
to also retain full functionality in vivo. However, none of the mutants could 
fully substitute for wild type RdgC in the three genetic backgrounds tested. 
In general, RdgC mutants with poor binding activity on short linear oligos 
retained very weak or no functionality in vivo, disregarding their affinities for 
circular DNA, such as RdgCE218R and RdgCK227A. As discussed in the previous 
section, the affinity of a mutant for circular DNA does not necessarily 
reflect how well it binds DNA. This could suggest linking RdgCs in vivo 
functionality directly to the tightness it binds DNA. For instance, RdgCE218R 
and RdgCK227A were poor short linear DNA binding proteins. Despite that their 
interfaces are closed tightly (good affinity for circular DNA), their weak 
interaction with DNA failed to deliver any valid wild type functionality in vivo 
(see Chapter 4 for details). 
As the data of the in vitro assays show, RdgC binds DNA probably by opening 
the ring, sliding onto its substrate and/or DNA-mediated dimerisation, but with 
a clear preference for the first. This exactly fits the data from in vivo assays, in 
which mutants with the ability to open the gate interface (e.g. RdgCH222A, 
RdgCK211A, RdgCR118A and RdgCR118C, see Chapter 4 and 5) generally retained 
more functionality than the ones without (e.g. RdgCFTM and RdgC¨F·R118C, see 
Chapter 6). RdgCR118A, RdgCR118C and especially RdgCK211A could substitute 
for wild type RdgC under many conditions. On the other hand, RdgCFTM was 
only poorly functional in priA- dnaC810 on LB and priA- pirC- dnaC809,820 
on MA; RdgC¨F·R118C was inactive in all conditions tested. 
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Another puzzle was raised by the mutants which showed wild-type like DNA 
binding activities in vitro, but had very poor or even no functionality in vivo, 
such as RdgCH222A and RdgCQ212A. Q212 was expected to form a triad with 
E218 and K227 (section 3.4), and the two histidines at 222 to interact with each 
other. The in vitro assays proved the roles of E218 and K227 in maintaining 
the horseshoe interface, as the substitutions greatly weakened the proteins 
linear DNA binding. The in vitro data suggest that Q212 does not interact with 
E218 and K227, nor do H222 with each other; or they do interact, but the 
interactions are less crucial in maintaining the configuration of the horseshoe 
interface. The crystal structure clearly supports the latter (Figure 4-1). However, 
the in vivo data revealed that Q212 and H222 are actually important for the 
proteins functionality. This could suggest an involvement of other important 
biological processes of Q212 and H222, or altered DNA binding activities 
undetected with the mutations. On the other hand, RdgCK211A has intact dimer 
interfaces, but its affinity for DNA is slightly reduced. In contrast to RdgCH222A 
and RdgCQ212A, RdgCK211A could substitute for wild type RdgC in most genetic 
background tested. The integrity of the horseshoe interface is therefore vital for 
RdgC in vivo functionality.  
7.4 How does RdgC regulate RecA’s activity? 
RecA has been found to be toxic in cells having defects in DNA replication 
restart system (Moore et al., 2003). Cells lacking PriA and RdgC and while 
carrying the dnaC810 suppressor of priA are barely viable on LB. This defect 
can be alleviated by removing recF, recO, recR or recA (R. G. Lloyd, 
unpublished data). It is therefore likely the RecFOR mediated RecA loading 
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pathway that contributes to the growth defect. The fact that priA- dnaC810 
rdgC
- cells grew on minimal medium indicate that toxic RecA loading is 
primarily a feature of cells growing rapidly in rich media. 
RecFOR are known to load RecA on ssDNA gaps. They first identify platforms 
for loading RecA, and then dislodge bound SSB proteins. With assistance from 
RecFOR, RecA nucleates on the ssDNA and the RecA:ssDNA filament 
extends within the region of ssDNA from 5-3 (Morimatsu and 
Kowalczykowski, 2003; Sakai and Cox, 2009). Thereafter, the RecA filament 
starts searching dsDNA homologous to the bound ssDNA. When suitable 
dsDNA molecule is found, the RecA filament aligns the bound ssDNA with it, 
and promotes a strand exchange between them. Considering RdgC as a DNA 
binding protein, it possibly regulates RecA activity either by binding to ssDNA 
gaps to limit RecAs loading, or by covering homologous dsDNA to prevent 
recombination.  
7.4.1 Does RdgC bind dsDNA to limit RecA activities? 
The central hole of the RdgC ring is well designed for dsDNA binding. The 
tight binding of RdgC to dsDNA would hinder the access to the dsDNA from 
RecA:ssDNA filaments. Its high affinity for dsDNA can even dislodge any 
RecA filaments already bound to dsDNA (Drees et al., 2006). It is generally 
true because most of the mutations that did not obviously affect the proteins 
dsDNA binding could substitute for wild type RdgC under certain conditions, 
such as RdgCK211A, RdgCR118C, RdgCR118A and RdgCH222A; whilst mutants with 
poor affinity for DNA were mostly inactive in vivo, such as RdgCE218R, 
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RdgCK227A, RdgC¨F and RdgCF120T. However, this model needs further 
evidence. Firstly, RdgC does not have any sequence or structural preference, 
and it only reaches 1000 copies per cell at its prime in the exponential phase, 
compared to 15,000 RecA molecules per cell (Moreau, 1987; Sassanfar and 
Roberts, 1990; Stohl et al., 2003). Both features will make the protein difficult 
to build barriers to RecA activities at hot spots. To overcome this, some yet 
unknown proteins may be required to recruit RdgC from the limited resources 
to sites where RecA activities need to be limited. Secondly, RdgCQ212A had 
dsDNA binding affinity comparable to the one of the wild type protein, but was 
inactive in all the genetic backgrounds tested. Although there could be 
undetected dsDNA binding defect of the mutant protein, the substitution might 
also interfere with possible protein-protein interactions, which may be also 
important to the wild type proteins function. Indeed, Escherichia coli DNA 
ligase, the ȕ subunit of the histone-like protein Hu and endonuclease V have 
been reported to interact with RdgC (Butland et al., 2005). DNA ligase 
catalyses the sealing of 5 phosphate and 3 hydroxyl termini at nicks in duplex 
DNA (Gottesman et al., 1973; Konrad et al., 1973; Sriskanda and Shuman, 
2001). Hu is one of the most abundant DNA-binding proteins in Escherichia 
coli, and it contributes to the compaction of the genome into tight nucleosome-
like structures (Rouvière-Yaniv et al., 1979). Neither of the proteins appears to 
be featured as RdgC recruiter, as they do not seem to bind specifically to 
dsDNA molecules that are potentially involved in illegitimate recombination. 
Endonuclease V, the gene product of nfi, is a DNA repair enzyme that repairs 
deaminated base damage by hydrolysing the second phosphodiester bond 3 
from a base lesion (Yao et al., 1994; Huang et al., 2001). Nonetheless, One of 
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its biochemical properties revealed by binding and kinetic analyses is the 
ability to remain bound to nicked deaminated lesions after strand cleavage 
(Yao and Kow, 1995; Huang et al., 2001), suggesting that it might recruit other 
proteins to assist the DNA repair. RdgC could be among the recruited proteins 
for limiting RecA access to the region, for recombining with a damaged duplex 
as a repair template is no good and sometimes can even be disastrous. However, 
more evidence needs to strengthen the idea, as the reported interactions 
between RdgC and other proteins could be indirect and mediated by DNA. 
The idea that RdgC has specific binding partners in E. coli might explain the 
failure of Neisseria RdgC protein to substitute for the native protein in E. coli. I 
made the relevant synthetic lethality constructs to test this and found that the 
heterogeneous protein did not allow recovery of plasmid-free cells (Appendix 
2). Given that Neisseria RdgC binds DNA much like the E. coli protein (Moore 
et al., 2004), the failure may reflect the fact that the RdgC binding partners are 
species specific. 
7.4.2 Does RdgC bind ssDNA to limit RecA activities? 
This possibility cannot be ruled out just because RdgC has relatively weaker 
affinity for ssDNA compared with dsDNA. RdgC has been reported to exhibit 
higher affinity for ssDNA with secondary structures, which resulted in a potent 
inhibition to RecA activities (Moore, 2002; Drees et al., 2006). The ability to 
bind ssDNA also does not conflict with the role of SSB. SSB is only inhibitory 
to RecA nucleation. Once nucleation completes (normally assisted by other 
regulatory proteins, such as RecFOR), the RecA:ssDNA filament readily 
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removes SSB at its 3 proximal end, and SSB facilitates the filament extension 
by removing secondary structures on ssDNA. RdgC offers complementary 
functions. Unlike SSB, RdgC does not bind ssDNA tightly, which leaves room 
for RecA loading. However, RdgC is able to stabilise secondary structures in 
ssDNA regions, and cannot be pushed off from ssDNA by RecA filament 
extension if the ssDNA region is flanked by dsDNA or secondary structures. 
Both features could limit RecA filament extension, but not RecA nucleation. 
Interestingly, ssDNA flanked by duplexes is a favourable substrate for 
RecFOR.  
This hypothesis is supported by the in vitro and in vivo mutant assays, where 
mutants with weak ssDNA binding also functioned very poorly in vivo. 
However, the data cannot discriminate between this model and the one 
proposed earlier in the previous section, since the weak ssDNA binding 
mutants generally also bound poorly to dsDNA. Inevitably, this model requires 
further evidence, too. The RdgC ring is designed well for dsDNA binding, but 
not for ssDNA. The main duty of the protein is probably achieved by dsDNA 
binding. The ssDNA binding is therefore at most a bonus to the protein if it is 
required in certain situations. Nonetheless, RdgCs slightly weak ssDNA 
binding necessitates its presence on ssDNA prior to RecA loading for any 
inhibitory effect to occur (Drees et al., 2006). Even under suitable conditions, 
such inhibitory effect requires large number of the RdgC proteins, exceeding 
its physiological sense. As the model proposed in 7.4.2, it therefore also needs 
a recruiter to guide the proteins to sites of interest. 
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7.4.3 Does RdgC need to bind both dsDNA and ssDNA to limit 
RecA activities? 
This is a tempting idea as RdgC can bind to both dsDNA and ssDNA. One 
interesting point is that the finger domains are evidently dispensable for a 
stable contact with dsDNA, but are crucial for interaction with ssDNA, as 
suggested by the in vitro investigation of RdgCFTM and RdgC¨F·R118C. In effect, 
RdgC will have optimum binding at dsDNA-ssDNA junctions, with full 
contact between the central hole and the dsDNA backbone, and with 
interaction between the ssDNA in vicinity and one of the fingers. Such 
junctions are exactly where the boundaries of ssDNA gaps are defined, a 
preferable target for RecFOR to load RecA. This model would allow limited 
number of RdgC proteins to be distributed specifically, and require only a few 
proteins per site for required activities. In fact, a recent study reported that 
RecFR binds randomly on dsDNA (Sakai and Cox, 2009). An unknown factor 
has therefore been proposed to guide RecFR complex to gap junctions, which 
in turn facilitates RecA loading with assistance from RecO (Sakai and Cox, 
2009). RdgC can also help restrict RecA filament extension within the region 
of ssDNA. This study indeed revealed RdgC with altered finger domains 
(responsible for ssDNA contact in this model) or weakened dsDNA binding 
had severely reduced activities in vivo. However, cells having defects in the 
RecFOR pathway are susceptible to DNA damage, a result of impaired 
recombinational DNA repair system, whereas deleting rdgC does not confer 
any obvious defects to the cells (Moore et al., 2003). It appears that the RecFR 
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complex is still capable of initiating RecA loading at appropriate sites in the 
absence of RdgC. 
To sum up, RdgC regulates RecA activities mainly by binding to DNA. 
Although I have proposed three models on how RdgC might achieve the effect, 
they are compatible with each other and might co-exist in vivo. 
 
7.5 RdgC in other species 
The rdgC gene is strictly distributed within ȕ and Ȗ subdivisions of 
Proteobacteria, including many of the human pathogens such as Neisseria 
meningitidis, Neisseria gonorrhoeae and Pseudomonas aeruginosa (Moore, 
2002).  
7.5.1 RdgC from Neisseria meningitidis and Neisseria 
gonorrhoeae 
RdgC from N. meningitidis shares 35% identity with the one from E. coli. 
Extensive studies performed by Moore and colleagues revealed its biochemical 
features very similar to E. coli RdgC, in that N. meningitidis RdgC also binds 
DNA with little specificity for sequence or structure (Moore et al., 2004). 
However, unlike its E. coli counterpart, N. meningitidis RdgC binds ssDNA 
almost as well as dsDNA (Moore et al., 2004). The similarity of the proteins in 
vitro activities suggests that RdgC performs a similar function in both E. coli 
and N. meningitidis. Indeed, this is probably true in N. gonorrhoeae, a very 
close relative of N. meningitidis. Under normal conditions, N. gonorrhoeae 
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undergoes frequent site-specific RecA-mediated recombinations to constantly 
change its pilin conformation, a process very important for the cells to evade 
the host immune response. This process is known as pilin antigenic variation, 
which has been found to require the RecFOR pathway to load RecA for 
recombination (Mehr and Seifert, 1998; Skaar et al., 2002). RdgC is also 
required because cells lacking it have 2-4 fold decreased pilin antigenic 
variation (Mehr et al., 2000). It is therefore obvious that RdgC is involved in 
the RecFOR-RecA mediated DNA recombination in N. gonorrhoeae. However, 
it is still not clear how RdgC contributes to the process. Given that another 
negative regulator of RecARecX, is also required in pilin antigenic variation, 
it is very likely that both RdgC and RecX act in concert to limit RecA activities 
to an appropriate level in Neisseria gonorrhoeae. 
In this work, I tested the RdgC protein from N. meningitidis with the synthetic 
lethality assays. Quite unexpectedly, the N. meningitidis protein did not 
substitute for E. coli wild type RdgC in any conditions tested (Appendix 2). As 
previously mentioned in 7.4.1, this is probably due to the species specific 
RdgC binding partners. Nonetheless, it is also possible that the relatively better 
ssDNA binding disables N. meningitidis RdgC in E. coli.  
7.5.2 RdgC from Pseudomonas aeruginosa 
The structure of RdgC from P. aeruginosa has recently been revealed as very 
similar to the one from E. coli (Figure 7-3) (Ha et al., 2007), and they share 
48% identity in amino acid sequence. 
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The two proteins share many of the conserved residues at both interfaces, and 
both have positively charged fingers (Figure 3-6). Although the group also 
failed to locate the bound dsDNA in the structure experimentally, they 
proposed the positively charged central hole as the binding channel (Ha et al., 
2007). The mutant studies by the group also established the importance of both 
of the interfaces to dsDNA binding. Interestingly, every tested mutation on 
conserved positively charged residues along the DNA binding channel had a 
considerable effect on dsDNA binding, even including the replacements to a 
neutral residue (alanine). Every basic residue in the central hole is therefore 
indispensable for a tight dsDNA binding. Substitutions at either interfaces had 
a similar effect on dsDNA binding as I observed on E. coli RdgC: F120A 
(counterpart of F120T and F120S in this study) was detrimental, and R211D 
(counterpart of K211A) was comparable to the wild type. The only difference 
rose from Q212A (same as in this study), which moderately weakened the P. 
aeruginosa proteins affinity for a 414bp dsDNA, but which did not effect 
much to the E. coli protein. The Q212 residue was also proposed to interact 
Figure 7-3 RdgC structures of Pseudomonas aeruginosa and Escherichia coli 
A. RdgC structure of P. aeruginosa (Ha et al., 2007) 
B. RdgC structure of E. coli (Briggs et al., 2007) 
A B
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with R211 and K227 in P. aeruginosa RdgC (Figure7-4) (Ha et al., 2007). The 
discrepancy might be due to the different experimental conditions:  the group 
performed the binding assay on agarose gel in TAE buffer (45 mM Tris-acetate 
at pH 8.3, 1 mM EDTA), whereas the one performed in this work was on poly-
acrylamide gel in LIS buffer. Of course it is also possible that both results were 
genuine and robust, and the discrepancy simply reflects different functions the 
Q212 residue delivers for the two proteins. It is also worth noting the fact that 
the Q212A mutation might weaken the proteins DNA binding affinity which 
correlates well with the results of the in vivo assays, where E. coli rdgCQ212A 
could not substitute for wild type rdgC in any condition tested. 
 
 
 
 
Given that P. aeruginosa RdgC has a structure very similar to the one of E. 
coli, it is fairly reasonable to suppose that Neisseria RdgC also adopts a similar 
protein fold. As the previous section discussed, although both proteins might 
Q212 
E218 
K227 
A B
Figure 7-4 Horseshoe interface comparison between E. coli RdgC and P. aeruginosa RdgC 
A. Horseshoe interface of E. coli RdgC 
B. Horseshoe interface of P. aeruginosa RdgC  
Corresponding residues are shaded in the same colour. 
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play a similar role in their native species, N. meningitidis RdgC could not 
substitute for the E. coli protein at all. In addition, it has a relatively better 
affinity for ssDNA than E. coli RdgC. Unfortunately, neither ssDNA binding 
of P. aeruginosa RdgC nor its in vivo substitution in E. coli has been tested. 
The two questions are therefore unable to be answered. I attempted to 
crystallise N. meningitidis RdgC, but the quality was too poor to be solved. 
7.6 Future directions 
This project offered a further understanding of RdgC as a DNA binding protein, 
with special reference to its structure and to how it loads onto DNA. However, 
how the RdgC protein is dislodged from DNA has not been studied. This is 
important in understanding why RdgCs DNA binding does not inhibit normal 
DNA processing, e.g. DNA replication and transcription. Competition 
experiments using various DNA molecules to compete for the RdgC already 
bound to DNA in conjugation with mutant studies might give insight into the 
mechanism of dissociation.  
Another perspective focuses on protein-protein interactions, as brought by 
several implications. Some RdgC mutants with disrupted horseshoe interface 
did not show a defect in DNA binding activities, whereas they lost most or all 
functionality in vivo (RdgCH222A and RdgCQ212A, see Chapter 4 for details). 
This leaves the horseshoe interface a potential as a protein interaction domain, 
although it is also possible that the interface mediates the formation of 
functional higher order oligomers. In the models proposed in 7.4.1, 7.4.2 and 
7.4.3, RdgC are all required to interact with proteins, either to be guided (7.4.1 
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and 7.4.2), or to guide certain functional proteins to sites of interest (7.4.3). As 
mentioned, several proteins have been reported to interact with RdgC, but this 
needs further validation. Other proteins with potential to interact with RdgC 
include RecF and RecR. Nonetheless, RdgC has been found to antagonise 
RecA activities by competing for its substrates (Drees et al., 2006). If this is the 
main activity of RdgC in vivo, then the same experiment design will expect to 
yield different results on RdgCQ212A and RdgCH222A, despite of their integral 
affinity for DNA. 
As mentioned in section 7.5.2, if we are lucky to have the rdgC gene from P. 
aeruginosa, we can therefore perform ssDNA and circular DNA binding assays, 
and make relevant synthetic lethality constructs to investigate whether it is able 
to substitute the E. coli rdgC. With the results we can probably get more 
insight into the proteins function on the structural level. 
7.7 Other ideas 
This project and many of the previous studies proved a strong link between 
RdgC and the RecFOR mediated RecA loading. However, in strains lacking 
RecBC and SbcBC, deletion of rdgC makes the strains growth dependent on 
the remaining RecA activities, mostly RecFOR mediated. This indicates that 
RdgC is also involved in some DNA repair process parallel to the one mediated 
by RecA. Indeed, the inviability seen in priA- rdgC- and priA- dnaC809,820 
priC
- rdgC- cells cannot be overcome by inactivating RecFOR or RecA (R. G. 
Lloyd, unpublished data), suggesting that the regulation of RecA is only part of 
RdgCs function in vivo. 
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The only conditions where the toxicity of RecA is revealed include priA- (R. G. 
Lloyd, unpublished data),  priA- rdgC- dnaC810 (R. G. Lloyd, unpublished data) 
and priA- rdgC- dnaC212 (Moore et al., 2003). In these conditions, Replication 
restart relies on Rep and PriC to load DnaB. It is therefore a putative target of 
toxic RecA activities. Rep together with PriC act in a way similar to PriA, 
where Reps 3-5 helicase activity unwinds the lagging strand to provide a 
landing pad for PriC, which in turn mediates loading of DnaB (Sandler, 2000). 
The only vulnerable moment for RecAs attack is after a segment of lagging 
strand is unwound by Rep and before PriC is in position. This ssDNA gap can 
be used by RecFOR to load RecA to initiate illegitimate recombination.  
If RdgC protects the process from being disrupted by RecA, then how is it 
achieved? The answer is not directly clear, as the ssDNA exposed by Rep is 
readily bound by SSB, and the opposite homologous leading strand does not 
appear to have any specific features that could attract enough RdgC for limiting 
recombination. A plausible answer is that RdgC could be directed by Rep to 
the unwound ssDNA and bind before SSB acts on it. In this case, Rep could be 
the putative guider as previously described in 7.4.2. 
The regulation of RecA by RdgC might be more than just by competing 
common substrates. A direct prediction of the competing model is that 
overexpressing RdgC in E. coli should confer phenotypes similar to those of 
cells lacking RecFOR, which have greatly reduced resistance to UV damage. 
However, cells had overexpressed RdgC did not show any defects in growth or 
UV resistance (unpublished data), which could mean that RdgC regulating 
RecA activities is directed. 
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Given the profile of RdgC we know so far, it is more like a dsDNA binding 
protein equivalent to SSB. SSB is known to exert a variety of activities by 
binding to ssDNA, mainly by protecting covered ssDNA from being abused 
and removing its secondary structures, a usual waylayer for normal ssDNA 
processing. In reflection, most or all functions of RdgC reported so far under 
certain conditions could simply use its dsDNA binding property. More 
interestingly, both proteins have similar expression levels in cells. 
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Appendix 1 
 
Proteins affinity for Heparin column 
Protein 
NaCl concentration range at elution 
peak (M) (Heparin column) 
E. coli native RdgC 0.70-0.90 
RdgCK211A 0.70-0.90 
RdgCQ212A 0.70-0.90 
RdgCE218R 0.70-0.90 
RdgCH222A 0.70-0.90 
RdgCK227A 0.50-0.70 
RdgCR118A 0.70-0.90 
RdgCR118C 0.70-0.90 
RdgC¨F 0.40-0.60 
RdgC¨FR118C 0.40-0.60 
RdgCF120T 0.70-0.90 
RdgCF120S 0.70-0.90 
RdgCR118CF120T 0.70-0.90 
RdgCFTM 0.50-0.70 
N. Meningitidis RdgC 0.70-0.90 
Se-Met RdgC 0.70-0.90 
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Appendix 2 
Synthetic lethality assay for N. meningitidis rdgC (NrdgC)
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